The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.
The June 2025 replay features four previously released stroke episodes. It begins with Dr. Cheryl Bushnell discussing the 2024 primary stroke prevention guidelines, followed by an interview with Dr. Phillip Ferdinand on the connection between smoking and young cryptogenic stroke. Next, Dr. Aaron Shoskes addresses the vascular risk burden in young adults with stroke. The replay concludes with Dr. Seemant Chaturvedi's overview from the International Stroke Conference.
Podcast links:
2024 Guideline for the Primary Prevention of Stroke
Association of Smoking and Young Cryptogenic Ischemic Stroke
Vascular Risk Factor Burden Among Young Adults with Ischemic Stroke
Overview from the 2025 International Stroke Conference
Article links:
2024 Guideline for the Primary Prevention of Stroke
Association of Smoking and Young Cryptogenic Ischemic Stroke: A Case-Control Study
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Drs. Sumanth Reddy and Jeffrey Gelfand about the complexities of small vessel predominant primary CNS vasculitis, clinical features, and the impact of early intensive immunosuppressive therapy on remission.
Read the related article in Neurology® Neuroimmunology & Neuroinflammation.
Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Dr. David A. Wolk about limbic predominant age-related TDP-43 encephalopathy (LATE) discussing its clinical features, diagnostic criteria, and the importance of recognizing this condition in the context of Alzheimer disease.
Read the related article.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Elia Sechi about the importance of understanding lab test results, the performance characteristics of assays, and the real-world implications of false positives in myasthenia gravis testing.
Read the related article in Neurology®.
Disclosures can be found at Neurology.org.
Dr. Roy E. Strowd talks with Dr. Susannah Cornes about a teaching incentive initiative designed to support and reward faculty in academic neurology.
Read the related article in Neurology® Education.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Per Borghammer about the classification of Lewy body disease into brain-first and body-first subtypes, with a focus on the newly identified parasympathetic and sympathetic subtypes within the body-first category.
Read the related article in Nature.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Janis Miyasaki about her journey into neurology, the integration of palliative care into neurologic practice, and the critical importance of patient-centered care.
Read more about the 2025 AAN President's Award.
Disclosures can be found at Neurology.org.
Dr. Jessica Ailani talks with Dr. Kathleen Digre about the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.
Disclosures can be found at Neurology.org.
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org.
The May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of immunoglobulin as a corticosteroid-sparing agent in MG patients. The third episode features Dr. Ali A. Habib discussing trends in hospital admissions and in-hospital mortality for adult MG patients. The series concludes with Dr. Jennifer Morganroth addressing the increase in thymectomy procedures post-MGTX trial, disparities in access to these surgeries among different demographic groups, and the rise of minimally invasive surgical techniques.
Podcast links:
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
Hospitalizations and Mortality from MG Hospitalizations and Mortality From Myasthenia Gravis
Trends and Disparities in the Utilization of Thymectomy for MG in the US
Article links:
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Hospitalizations and Mortality From Myasthenia Gravis
Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States
Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient.
Read the related article in Nature.
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Paula Marques about sex differences in genetically determined epilepsies.
Read the related article in Neurology® Genetics.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Peter Goadsby about advances in headache science and classification.
Read the editorial about ICHD-4.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Harry W. Sutherland about diversity in teaching methods, the balance between clinical responsibilities and educational opportunities, and innovative models like the academic half day.
Read the related article in Neurology® Education.
Disclosures can be found at Neurology.org.
Dr. Jessica Ailani talks with Dr. Richard B. Lipton about the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice.
Read the related article with Neurology® Clinical Practice.
Disclosures can be found at Neurology.org.
Prof. Jon Stone talks with Dr. Laura Strom and Meagan Watson about changes in total emergency department and inpatient visits and costs before and after referral to a specialized, comprehensive functional seizure treatment clinic.
Read the related article with Neurology® Clinical Practice.
Disclosures can be found at Neurology.org.
Neurology® Open Access has officially launched.
In this episode, Dr. Jeff Ratliff and NOA Editor, Dr. Amy C. Kunchok share insights about Neurology® Open Access (NOA).
Read more about Neurology® Open Access in this editorial, and visit the Neurology® Open Access website.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Mehari Gebreyohanns, the recipient of the 2025 Ted Burns Humanism in Neurology Award, about his journey into stroke care, the BORNE initiative, and the challenges faced in global neurology.
Disclosures can be found at Neurology.org.
The April 2025 replay showcases five compelling physician-as-patient stories. The episode begins with Dr. Franzi Herpich sharing her personal experience of suffering a stroke. It then transitions into a two-part series on arteriovenous malformation, featuring stories from Dr. Joe Sirven and Dr. Amy Hessler. The fourth episode highlights Dr. Eric Seachrist's journey with multiple sclerosis. In the final episode, Dr. Andrea Lendaris discusses her experience with Usher syndrome type 2A and her ongoing battle with acute and chronic health challenges.
Podcast links:
Physicians as Patients Series - Arteriovenous Malformation - Part 1
Physicians as Patients Series - Arteriovenous Malformation - Part 2
Physician as Patient Series - Multiple Sclerosis
Physicians as Patients Series - Inclusivity of Physicians with Disabilities
April 2022 Recall: Physician as Patient
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Dr. Jennifer Morganroth about the increase in thymectomy procedures following the MGTX trial, the differences in access to these surgeries among various demographic groups, and the growing role of minimally invasive surgical techniques.
Read the related article in Neurology® Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Andrea Gropman talks with Dr. Stefan Pulst about the significant advancements in Neurology® Genetics over the past decade.
Read the related article in Neurology® Genetics.
Disclosures can be found at Neurology.org.
Dr. Jessica Ailani talks with Dr. Francesca Puledda about the International Headache Society's global practice recommendations for the acute and preventive treatment of migraine.
Read the related recommendations for the acute pharmacological treatment of migraine in Sage Journals.
Read the related recommendations for pharmacological treatment of migraine in Sage Journals.
Disclosures can be found at Neurology.org.
Dr. Dan Ackerman talks with Dr. Phillip Ferdinand about the association between smoking and young cryptogenic ischemic stroke.
Read the related article in Neurology® Open Access.
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Dr. Timothy Miller about compelling patient stories and clinical data that highlight the potential for recovery in ALS patients, emphasizing the importance of early intervention and understanding the disease mechanisms.
Disclosures can be found at Neurology.org.
Dr. Trey Bateman talks with Dr. Amy Brodtmann about the complexities of diagnosing FTD and related disorders, emphasizing the need to understand frontal network impairments and the importance of behavioral assessments and psychiatric history in clinical practice.
Read the related article in Neurology® Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Patricia Pozo-Rosich about the latest advancements in headache medicine, focusing on key research findings from 2024.
Dr. Alison Christy talks with Dr. Wallace J. Brownlee about whether dissemination in time (DIT) is necessary to make a diagnosis of MS in patients who fulfill a high number of dissemination in space (DIS) criteria.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about the latest findings from the International Stroke Conference, focusing on advancements in stroke treatment and recovery.
Read more about the ESCAPE-MeVO trial.
Read more about the Distal trial.
Read more about the ANGEL-TNK trial.
Read more about the PRESTIAGE-AF trial.
Read more about the TRANSPORT2 trial.
Disclosures can be found at Neurology.org.
The March 2025 replay features four previously released episodes focused on peripheral neuropathy and radiculopathy. The episode begins with Dr. Anne Oaklander discussing the association between long COVID and the development of polyneuropathy affecting small-fiber axons. This is followed by another interview with Dr. Oaklander, where she shares key takeaways for clinicians regarding the management of small-fiber neuropathy. The third segment features Drs. Raymond Price and Brian Callaghan discussing practice guidelines for painful diabetic neuropathy. The episode concludes with Dr. Carmel Armon addressing the efficacy of epidural steroid injections in treating cervical and lumbar spinal stenosis and radiculopathies.
Podcast Links:
Peripheral Neuropathy and Prolonged COVID
Relapsing-Remitting Immunotherapy Responsive SFN
Practice Guidelines for Painful Diabetic Neuropathy
Epidural Steroids for Cervical and Lumbar Radicular Pain and Spinal Stenosis
Article Links:
Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID
Relapsing-Remitting Immunotherapy Responsive Small-Fiber Neuropathy
Disclosures can be found at Neurology.org.
Dr. Vikram Karnik talks with Dr. Lorraine V. Kalia about the potential role of GLP-1 receptor agonists in neurodegenerative diseases, the current state of research, preclinical evidence, and future directions for GLP-1 agonists.
Read the related article in The Lancet.
Disclosures can be found at Neurology.org.
Dr. BJ Hicks talks with Dr. Aaron Shoskes about the rising incidence of ischemic stroke in young adults.
Read the related article in Neurology®.
Disclosures can be found at Neurology.org.
Dr. Alex Menze talks with Dr. Carmel Armon about the efficacy of epidural steroid injections in cervical and lumbar spinal stenosis and radiculopathies, assessing short-term and long-term improvements in pain and disability.
Read the related article in Neurology®.
Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Dr. Gregg Day about practical approaches for screening assessments and preventive interventions that neurologists can implement to enhance the brain health of their patients at all stages of life.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Shuvro Roy talks with Dr. Giovanna S. Manzano about the management of neurosarcoidosis, highlighting the challenges in diagnosis, treatment approaches, and the importance of collaboration among specialists.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Greg Cooper discusses with Dr. Dean Ornish how lifestyle interventions can significantly enhance cognition and function in patients, providing hope where traditional drug treatments have fallen short.
Read the related article in Springer Nature.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. John W. Winkelman about the new clinical practice guidelines for treating restless legs syndrome and periodic limb movement disorder, covering diagnosis, treatment options, and future management insights.
Read the related article in the Journal of Clinical Sleep Medicine.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. John W. Winkelman about the new clinical practice guidelines for treating restless legs syndrome and periodic limb movement disorder, covering diagnosis, treatment options, and future management insights.
Read the related article in the Journal of Clinical Sleep Medicine.
Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Prof. Gill Livingston about new hopeful evidence about dementia prevention, intervention, and care.
Read the related article in The Lancet.
Disclosures can be found at Neurology.org.
The February 2025 replay showcases four episodes on the topic of neurology education. The episode begins with Drs. Dara V. F. Albert and Afsaneh Talai addressing the gaps in resident education on psychogenic nonepileptic seizures. This is followed by an engaging interview with Drs. Sarah Louise Edwards and Zachary London, who delve into the current state of game-based learning in neuroscience education. In the third episode, Dr. Catherine Albin discusses the essential elements of effective educational social media posts. The series concludes with Drs. Rachel Gottlieb-Smith and Kathryn Xixis examining the impact of artificial intelligence on residency recruitment.
Podcast Links:
Educating Child Neurology Residents About PNES
Game Based Learning in Neuroscience
Features of Educational Social Media Posts
Artificial Intelligence in Residency Recruitment
Article Links:
Education Research: Educating Child Neurology Residents About Psychogenic Nonepileptic Seizures
Artificial Intelligence in Residency Recruitment
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Nico U. F. Dosenbach about the brain's action mode network, focusing on resting state functional connectivity and the significance of the action mode network in relation to other networks.
Read the related article in Nature Reviews Neuroscience.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Josep Dalmau about the evolution of Neurology: Neuroimmunology & Neuroinflammation over the past decade, and how it has emerged as a leading journal in clinical and translational neuroimmunology.
Read the related article in Neurology: Neuroimmunology & Neuroinflammation.
Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Adam Rodman about the implications of large language models in clinical reasoning and diagnostics.
Read the related article on arXiv.
Disclosures can be found at Neurology.org.
Dr. Derek Stitt talks with Dr. Miranda M. Wan about improving training and public awareness to optimize palliative care for patients with neurologic conditions.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Alexander Menze talks with Dr. Adrian Budhram about the common challenges faced by neurologists when interpreting cerebrospinal fluid (CSF) results, particularly in cases of traumatic lumbar punctures.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Trey Bateman talks with Dr. Simon Ducharme and Tristin Best about changes in hypothalamic structure across the lifespan in patients with genetic FTD and whether these changes related to sleep dysfunction.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Nicolás Lundahl Ciano-Petersen about the clinical and immunologic profile of patients with paraneoplastic neurologic syndromes associated with Merkel cell carcinoma.
Read the related article in Neurology: Neuroimmunology & Neuroinflammation.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Ashish D. Patel about headache referrals and the implementation of a design thinking approach to improve access to headache care.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Scott Friedenberg about the challenges faced by neurologists in balancing financial productivity with optimal patient care
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Ring in the new year with the January 2025 replay of previously released episodes discussing the rise of science sleuths. In this three-part series Dr. Stacey Clardy talks with Dr. Elisabeth Bik and Dr. Matthew Schrag about critical issues surrounding research integrity and misconduct.
Podcast Links:
The Rise of the Science Sleuths - Part 1
The Rise of the Science Sleuths - Part 2
The Rise of the Science Sleuths - Part 3
Article Link:
The Rise of the Science Sleuths
Disclosures can be found at Neurology.org.
Dr. Neha Dangayach talks with Drs. Yelena Bodien and Brian Edlow about the concept of cognitive motor dissociation (CMD) in neurocritical care, highlighting its implications for patient assessment and treatment.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Shuvro Roy talks with Dr. Marisa Patryce McGinley about outpatient telemedicine utilization for neurologic conditions and identify potential disparities.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Cheryl Bushnell about the significance of these guidelines, essential messages for clinicians, lifestyle factors influencing stroke risk, unique considerations for women’s health, and the necessity to bridge knowledge gaps in stroke prevention.
Read the 2024 Guideline for the Primary Prevention of Stroke.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Ron Postuma about the clinical features associated with IGLON5 positivity, emphasizing the implications for practitioners in diagnosing and treating sleep and movement disorders.
Read the related article in Neurology: Neuroimmunology & Neuroinflammation.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Drs. Rachel Gottlieb-Smith and Kathryn Xixis about the impact of artificial intelligence on residency recruitment in neurology, focusing on its potential benefits and pitfalls.
Read the related article in Neurology: Education.
Disclosures can be found at Neurology.org.
Dr. Derek Stitt talks with Dr. Reece Hass about the neuroanatomy of the cough reflex, the relationship between cough and pain, and specific neurological conditions that can lead to neurogenic cough.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Drs. Claire J. Creutzfeldt and Robert G. Holloway about the concept of medical forecasting, its importance in clinical practice, and the skills necessary for effective prognostication.
Read the related article in JAMA.
Disclosures can be found at Neurology.org.
Dr. Vikram Karnik talks with Dr. Kate Wyman-Chick about distinguishing prodromal dementia with Lewy bodies from prodromal Alzheimer disease, the importance of early diagnosis, and the implications for clinical practice.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Bhooma Aravamuthan about the modern definition of cerebral palsy, the philosophical implications of diagnostic labels, and the need for clarity in clinical practice.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
The December 2024 replay wraps up the year with five previously posted episodes on autoimmune neurology. The episode begins with Drs. Michael R. Wilson and John Pluvinage discussing transcobalamin antibodies. The episode leads into an interview with Dr. Andrew McKeon, who talks about paraneoplastic CAMKV autoimmune encephalitis. In the third episode, Dr. Maarten Titulaer discusses long-term outcomes and rehab in NMDAR encephalitis. The episode continues with Prof. Zsolt Illes discussing the mortality of patients with AQP4 antibody–seropositive neuromyelitis optica spectrum disorder compared with that in the general population. In the final episode, Drs. Marius Ringelstein and Ilya Ayzenberg discuss the effectiveness and safety of Eculizumab in routine clinical care.
Podcast Links:
Transcobalamin receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency
Paraneoplastic CAMKV Autoimmune Encephalitis
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis
Mortality in a Danish NMO Cohort
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
Article Links:
Transcobalamin Receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Vineet Punia about factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures.
Read the related article in JAMA.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Catherine Albin about the key features of educational social media posts, strategies for creating impactful content, the importance of visual appeal, and the role of community engagement in neurology education.
Read the related article in Neurology: Education.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Maarten Titulaer about long-term cognitive and functional outcomes in patients with anti-NMDAR encephalitis and their implications for rehabilitation.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Elias Sotirchos about the underlying etiologies of myelitis in patients with rheumatologic disease.
Read the related article in Neurology: Neuroimmunology & Neuroinflammation.
Disclosures can be found at Neurology.org.
Dr. Gregg Day talks with Dr. Kathryn T. Hall about the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Ahmad Nehme about the complexities of diagnosing and differentiating between cerebral amyloid angiopathy-related inflammation and biopsy-positive primary angiitis of the central nervous system.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
In the concluding segment of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about genetic leukodystrophies and the increasing recognition of these disorders in adult neurology, the importance of genetic testing, and the evolving treatment landscape.
Read the related articles in Neurology and CHS Perspectives.
Disclosures can be found at Neurology.org.
In the first part of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about a practical approach to genetic leukodystrophies, focusing on the importance of genetic testing, identifying red flags in patients, and navigating the complexities of hereditary spastic paraplegia.
Read the related articles in Neurology and CHS Perspectives.
Disclosures can be found at Neurology.org.
The November 2024 replay features four episodes dedicated to brain health. It kicks off with an interview with Dr. Nicoline Schiess, who discusses the World Health Organization (WHO) Brain Health Unit. Next, Dr. Katrin Seeher delves into the global burden of neurological conditions and the WHO’s strategies to enhance care and awareness. The third segment features Dr. Natalia Rost who introduces and highlights the American Academy of Neurology’s (AAN) groundbreaking brain health initiative. The episode wraps up with Dr. Rost again, who returns to give an update and emphasize the urgency of addressing brain health amidst public health challenges.
Podcast Links:
Global Burden of Neurologic Conditions
Brain Health Initiative with Dr. Natalia Rost
Update on Brain Health with Dr. Natalia Rost
Article Links:
The Brain Health Imperative in the 21st Century—A Call to Action
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Drs. Marius Ringelstein and Ilya Ayzenberg about the effectiveness and safety of Eculizumab in routine clinical care.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Drs. Messoud Ashina and Andrea Cipriani about all licensed drug interventions as oral monotherapy for the acute treatment of migraine episodes in adults.
Read the related article in the BMJ.
Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Dr. Clifford R. Jack Jr about objective criteria for diagnosis and staging Alzheimer disease, highlighting recent advancements in biomarkers to bridge the gap between research and clinical practice.
Read the related article in Alzheimer's Association.
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Dr. Whitley Aamodt about end-of-life care for patients with neurodegenerative diseases, focusing on healthcare utilization, hospice enrollment, and the importance of early conversations about care preferences.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Kait Nevel talks with Dr. Oumaima Aboubakr about the prevalence of epilepsy in primary CNS lymphoma, to identify factors associated with epilepsy, and to investigate the prognostic significance of seizures in PCNSL.
Read the related article in Neurology®.
Disclosures can be found at Neurology.org.
In the final part of this three-part series, Dr. Stacey Clardy talks with Drs. Elisabeth Bik and Matthew Schrag about the challenges posed by AI in generating fraudulent research, the importance of cultural solutions to uphold scientific integrity, and the need for modernized data management practices in research.
Read the related article in Undark.
Disclosures can be found at Neurology.org.
In part two of this special three-part series, Dr. Stacey Clardy talks with Drs. Elisabeth Bik and Matthew Schrag about the processes involved in addressing concerns about research integrity, covering the role of public platforms, using social media for awareness, identifying potential research fraud, and the need for cultural change within the scientific community to prioritize ethical practices.
Read the related article in Undark.
Disclosures can be found at Neurology.org.
In the first part of this special three-part series, Dr. Stacey Clardy talks with Drs. Elisabeth Bik and Matthew Schrag about critical issues surrounding research integrity and misconduct.
Read the related article in Undark.
Disclosures can be found at Neurology.org.
Dr. Farrah Mateen talks with Dr. Katrin Seeher about the significant global burden of neurologic conditions, which affects over 3.4 billion people worldwide, and the strategies the WHO is implementing to improve care and awareness.
Read the related article in The Lancet Neurology.
Disclosures can be found at Neurology.org.
In the October 2024 replay features four episodes on approaches to clinical diagnosis of parkinsonism. The episode starts off with Dr. Colin Hoy discuss the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis. The episode leads into a conversation with Dr. Chris Gibbons discussing skin biopsies to detect phosphorylated α-synuclein. In the third episode Drs. Michiko K. Bruno and Lawrence Golbe about a practical diagnostic algorithm for atypical parkinsonian disorders Drs. Michiko K. Bruno and Lawrence Golbe discuss a practical diagnostic algorithm for atypical parkinsonian disorders. The episode concludes with Dr. Eduardo De Pablo-Fernández talking about the strengths of DAT imaging in diagnosing patients with Parkinsonian disorders.
Previous Podcasts:
The Ethical Landscape of Prodromal Parkinson Disease
Skin Biopsy Detection of Phosphorylated α-Synuclein
General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders
Interpreting DAT Imaging Results in the Clinical Context
Article Links:
The Ethical Landscape of Prodromal Parkinson Disease
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Drs. Nanditha Rajamani and Andy Horn about the challenges faced in current deep brain stimulation practices and the potential for data-driven approaches to enhance treatment outcomes.
Read the related article in Nature Communication.
Disclosures can be found at Neurology.org.
Dr. Shuvro Roy talks with Dr. Anne Louise Oaklander about the big-picture takeaways for clinicians in the context of managing small-fiber neuropathy.
Read the related article in Neurology® Neuroimmunology & Neuroinflammation.
Disclosures can be found at Neurology.org.
Dr. Dara Albert talks with Dr. Jaclyn M. Martindale about the differences in gender representation among leadership positions and award recipients within the Child Neurology Society.
Read the related article in Neurology®.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Drs. Michiko K. Bruno and Lawrence Golbe about a practical diagnostic algorithm for atypical parkinsonian disorders, emphasizing the importance of recognizing these conditions in clinical practice.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Drs. Shahar Shelly and Teerin Liewluck about the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Messoud Ashina about the biology of PACAP, its significance in relation to migraines, and its potential as a novel therapeutic approach.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
Dr. Amy Gelfand talks with Dr. Matthew Bender about the possible association between glymphatic outflow and extent of transverse sinus stenosis in patients with intracranial hypertension.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. David Perez talks with Dr. Glenn Nielsen about the effectiveness of physiotherapy in treating functional motor disorder and to determine the best approach for physiotherapy treatment.
Read the related article in The Lancet.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Mary Schroth about the revised SMA recommendations, treatment options available, treatment outcomes, and the future of SMA research and care.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
The September 2024 recall features previously posted Neurology Minute episodes by Dr. Alison Christy, focusing on Women in History Minutes. Dr. Christy has curated an outstanding series highlighting numerous women and their significant contributions to the field of neurology. In honor of Women in Medicine Month, we’ve compiled some of the best moments from her series to celebrate these remarkable pioneers. Tune in to celebrate the remarkable contributions of these women and their lasting impact on the medical field.
Disclosures can be found at Neurology.org.
Dr. Gregg Day talks with Dr. Sebastian Palmqvist about the use of blood biomarkers to streamline the diagnostic workup and treatment of Alzheimer disease.
Read the related article in JAMA.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Calum Alexander Hamilton about the importance of tracking and managing patients with MCI, especially those with Lewy body pathology.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Nicola de Souza about neuropsychological profiles of deployment-related mild traumatic brain injury and post-traumatic stress disorder among service members and veterans.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Daniel Weintraub about the long-term dementia risk in Parkinson disease using data from two large, ongoing, prospective, observational studies.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Eduardo De Pablo-Fernández about the strengths of DAT imaging in diagnosing patients with Parkinsonian disorders.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Dan Ackerman talks with Dr. Luciano A. Sposato about the topic of embolic stroke of undetermined source and the controversies surrounding cardiac monitoring and anticoagulation.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Dan Ackerman talks with Dr. Gaspard Gerschenfeld about the efficacy and safety of both thrombolytics in patients with large ischemic core.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Colin Hoy about the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
The August 2024 recall showcases four previously posted episodes on the topic of Multiple Sclerosis. In the first episode, Dr. Géraldine Androdias discusses the impact of immune checkpoint inhibitors on multiple sclerosis. The episode leads into Dr. Bob Fox discussing the relationship between sNfL levels and radiologic activity in multiple sclerosis. In the third episode, Dr. Ellen Iacobaeus discusses the clinical characteristics of late-onset multiple sclerosis. The last episode leads into a conversation with Dr. Riley Bove discussing navigating family planning and pregnancy in patients with multiple sclerosis.
Article Links:
Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis
Multiple Sclerosis and Family Planning: A Survey Study of the Patient Experience
Podcast Links:
Impact of Immune Checkpoint Inhibitors
sNfL and Radiologic Disease Activity in Patients With MS
Clinical Characteristics and Long-Term Outcomes of Late-Onset MS
Multiple Sclerosis and Family Planning
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Kimford J. Meador about perinatal exposure to anti-seizure medications and its effects on creativity and executive function in children.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Matthew Barrett talks with Dr. Michael S. Okun about the caution and deliberation needed in understanding Parkinson disease biomarkers.
Read the related viewpoint piece in JAMA Neurology.
Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Lidia Moura about the implications of large language models (LLMs) for neurologic care.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Drs. Michael R. Wilson and John Pluvinage about their discovery of anti-CD320 antibodies in patients with neurologic manifestations of B12 deficiency and discuss the potential implications for diagnosis and treatment.
Read the related article in Science.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Campbell Le Heron about the association of clinical and neurocognitive factors with apathy in patients with Parkinson disease.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Andrew McKeon about the topic of autoimmune neurology, specifically focusing on the antibody CAMKV and its association with autoimmune encephalitis.
Read the related article in Annals of Neurology.
Disclosures can be found at Neurology.org.
Dr. Jessica Ailani talks with Dr. Ian Carroll about intracranial hypotension, the challenges of diagnosing and treating patients with CSF leaks, and the study's findings.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Eric Seachrist about his experience with multiple sclerosis.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Carlayne E. Jackson about the state of neurology and the challenges and opportunities facing the field.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference.
Show references:
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE)
Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
The July 2024 replay of past episodes showcases four incredible interviews on infectious and post-infectious neurology. The episode begins with Dr. Alice Tang discussing the association between immune status and herpes simplex virus encephalitis. The episode leads into Dr. Haya Bishara talking about GBS and COVID-19 infection. In the third episode, Dr. Adam de Havenon talks about neurologic diagnoses in the year after COVID-19 vs. Influenza. The episode concludes with Dr. Avindra Nath talking about new research related to post-infectious myalgic encephalomyelitis/chronic fatigue syndrome.
Article Links:
Podcast Links:
Herpes Simplex Virus Encephalitis
Guillain-Barré Syndrome and COVID-19 Infection and Vaccination
Neurologic Diagnoses after COVID-19 or Influenza Hospitalization
Post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Michael Marmura about the definition of refractory headache, the challenges in treating migraine, the role of comorbidities, and the importance of accurate diagnosis.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Natalia Rost about the American Academy of Neurology’s groundbreaking brain health initiative.
Read more about the Brain Health Initiative.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Jennifer Robblee and Dr. Lawrence Robbins about how to diagnose and manage refractory headaches.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Prof. Zsolt Illes about the mortality of patients with AQP4 antibody–seropositive neuromyelitis optica spectrum disorder compared with that in the general population.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Dan Ackerman talks with Dr. Andy Southerland about the impact of glucose control on the risk of symptomatic intracerebral hemorrhage following thrombolysis for acute ischemic stroke.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Messoud Ashina about the comparison between cortical morphometry to a large sample of people with migraine and healthy controls, as well as across migraine subtypes.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Avindra Nath about new research related to post-infectious myalgic encephalomyelitis/chronic fatigue syndrome.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Dan Ackerman talks with Dr. Silja Räty about the outcomes of patients with basilar artery occlusion treated with intravenous thrombolysis (IVT) only and compares IVT with endovascular thrombectomy.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
The June 2024 replay features four previously showcased episodes on topics in epilepsy. The episode begins with Dr. Genevieve Rayner and Eliza Honybun discussing the relationship between prenatal antiseizure medication exposure and adverse postnatal neurodevelopmental outcomes. The second episode leads into a conversation with Drs. Drs. Jacqueline French and Nora Jandhyala on the recognition of motor vs. non-motor seizures and its effect on the management and treatment of focal epilepsy in adolescents. The episode continues with Dr. Valérie van Hezik-Wester discussing the effectiveness of seizure dogs. The episode concludes with Dr. Fred Lado discussing the updated guidelines for specialized epilepsy centers.
Article Links:
Podcast Links:
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Emanuele Cerulli Irelli about the research on seizure recurrence in women with idiopathic generalized epilepsy who switch from valproate to another medication.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Andrea Lendaris about her experience of having Usher syndrome type 2A along with her journey of having acute and chronic health challenges.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Maureen Leehey about the short-term efficacy and tolerability of high-CBD/low-THC cannabis extract on the motor symptoms in patients with Parkinson disease.
Read the related article in the International Parkinson and Movement Disorder Society.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Drs. Sarah Louise Edwards and Zachary London about the current state of game-based learning in neuroscience education.
Read the related article in Neurology: Education.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Howard Goodkin talks with Dr. Alison M. Pack about the new updated guidelines piece on the conclusions and recommendations regarding the effects of antiseizure medications and folic acid supplementation on the prevalence of MCMs, adverse perinatal outcomes, and neurodevelopmental outcomes in children born to PWECP.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Derek Stitt talks with Dr. Adam de Havenon about the burden of neurologic health care and incident neurologic diagnoses in the year after COVID-19 vs influenza.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Vikram Karnik talks with Dr. Rob de Bie about early vs. delayed start of Levodopa in early Parkinson disease, and what it means for clinical practice.
Read the related article in International Parkinson and Movement Disorder Society.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Alice Tang about the association between immune status and herpes simplex virus encephalitis.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Drs. Jacqueline French and Nora Jandhyala about investigating ED recognition of motor vs. non-motor seizures and its effect on the management and treatment of focal epilepsy in adolescents.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
The May 2024 replay features four episodes on neuro-oncology for brain cancer awareness month. The episode begins with Dr. Philipp Karschnia discussing the assessment of whether MTHFR polymorphisms affect the risk for leukoencephalopathy. The episode continues with Dr. Ingo Mellinghoff discussing new treatment opinions for isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. The third interview leads into a conversation with Dr. Linda Liau on the study of vaccine-based therapy for GBM. The episode concludes with Dr. Teddy Totimeh talking about brain tumor programs in Asia and Africa.
Podcast Links:
MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients
New Treatment for IDH mt Gliomas
Study of Vaccine-Based Therapy for GBM
Brain Tumor Programs in Asia and Africa
Article Links:
https://doi.org/10.1212/WNL.0000000000207670
https://www.nejm.org/doi/full/10.1056/NEJMoa2304194
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://doi.org/10.1016/j.wneu.2023.04.067
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Bob Fox about the relationship between serum neurofilament light chain (sNfL) levels and radiologic multiple sclerosis disease activity.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Ellen Iacobaeus about patient characteristics, disease-modifying therapy, and disability progression in Swedish patients with late-onset MS and adult-onset MS over 2 decades.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Chris Gibbons about the use of skin biopsies to detect phosphorylated α-synuclein in individuals with synucleinopathies such as Parkinson disease, multiple system atrophy, dementia with Lewy bodies, and pure autonomic failure.
Read the related article in JAMA.
Disclosures can be found at Neurology.org.
As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Amy Hessler about her experience with a ruptured arteriovenous malformation as a 2nd-year neurology resident.
Disclosures can be found at Neurology.org.
As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Joe Sirven about his experience with a ruptured arteriovenous malformation. If you're attending the AAN Annual Meeting in Denver, you can catch this conversation and more in a live Q&A session on April 16th at 2:30 pm MT at the publication stage.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Drs. Dara V. F. Albert and Afsaneh Talai about understanding the gaps in resident education on psychogenic nonepileptic seizures.
Read the related article in Neurology: Education.
Disclosures can be found at Neurology.org.
Dr. Kait Nevel talks with Dr. Elizabeth Gerstner about the use of CAR-T cells in the treatment of glioblastoma.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Géraldine Androdias about the impact of immune checkpoint inhibitors on the course of multiple sclerosis.
Read the related article in Neurology: Neuroimmunology and Neuroinflammation.
Disclosures can be found at Neurology.org.
Dr. Jessica Ailani talks with Dr. Ron (W.P.J.) van Oosterhout about the occurrence, characteristics, and evolution of space headaches during long-duration flights.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
The April 2024 replay of past episodes showcases four incredible interviews on functional neurologic disorders. The episode begins with the 3-part FND roundtable discussion with Prof Jon Stone discussing various topics in FND with Drs. Selma Aybek, David Perez, and Sarah Lidstone. In the first discussion they touch on FND diagnosis and exploring new phenotypes. The second discussion is on how and why FND and the third discussion is on treatments for FND. The episode concludes with Dr. Halley Alexander’s conversation with Dr. Genna Waldman about reviewing psychogenic non-epileptic events.
Related Links:
Disclosures can be found at Neurology.org.
Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Read the related article in Neurology: Neuroimmunology and Neuroinflammation.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff speaks with Dr. Avindra Nath, the recipient of the 2024 American Brain Foundation Ted Burns Humanism in Neurology Award.
Read more about the Ted Burns Humanism in Neurology Award.
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Valérie van Hezik-Wester about whether people living with severe medically refractory epilepsy (PSRE) benefit from a seizure dog.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Genevieve Rayner and Eliza Honybun about the relationship between prenatal antiseizure medication exposure and adverse postnatal neurodevelopmental outcomes.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Carles Gaig about developing a composite score to assess the severity of the multiple symptoms present in anti-IgLON5 disease.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Aaron Baldwin about how access to genetic testing may vary based on various factors such as race, ethnicity, sex, socioeconomic status, and insurance status.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Deanna Saylor talks with Drs. Gretchen Birbeck and Melody Asukile about ways to improve global collaboration among neurologists.
Read the related article in JAMA Neurology.
Disclosures can be found at Neurology.org.
Dr. Howard Goodkin talks with Dr. Fred Lado about the National Association of Epilepsy Centers (NAEC) updated guidelines for specialized epilepsy centers.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
The March 2024 recall includes three episodes taken from the 2023 November Headache Series. In part two of this two-part recall, Dr. Tesha Monteith begins with a discussion with Dr. Messoud Ashina on the mechanisms of migraine. The episode continues with Dr. Peter Goadsby talking about updates on migraine treatments and CGRP inhibitors. Finally, the episode concludes with an interview with Dr. Stewart Tepper discussing rapid developments in neuromodulation.
Related Podcast Links:
https://directory.libsyn.com/episode/index/id/28721028
https://directory.libsyn.com/episode/index/id/28812568
https://directory.libsyn.com/episode/index/id/28868248
Disclosures can be found at Neurology.org
Dr. Tesha Monteith talks with Dr. Robert Evan Shapiro about the impact that migraine has on quality of life and the frequency of migraine-related stigma.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Shuvro Roy talks with Dr. Riley Bove about managing patients with multiple sclerosis as they navigate family planning and pregnancy.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Subhojit Roy about a platform for investigating the role of serine-129 in synucleinopathies, with implications for drug development.
Read the related article in the Neuron.
Disclosures can be found at Neurology.org.
Dr. Gregg Day talks with Drs. Thomas J. Montine and Brenna Cholerton about whether the association between neuropathologic burden and dementia in these older groups differs substantially from those seen in younger-old adults.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Derek Stitt talks with Dr. David T. Plante about the Wisconsin Sleep Cohort study to estimate the prevalence of idiopathic hypersomnia.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Prof. Xavier Ayrignac about the importance of considering alternative diagnoses for CTLA4 deficiencies.
Read the related article in Neurology.
Dr. Stacey Clardy talks with Bob Herman about a class action lawsuit that was filed against UnitedHealth Group and its subsidiary, NaviHealth, for using a computer algorithm to "systematically deny claims” of Medicare beneficiaries struggling to recover from debilitating illnesses in nursing homes.
Read the related article in STAT News.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Jason Margolesky about the frequency of blepharoclonus in Parkinson disease and atypical Parkinsonian disorders to explore whether this clinical phenomenology may be useful in the evaluation and diagnosis of patients with Parkinsonism.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
The February 2024 recall includes three episodes taken from the 2023 November Headache Series and will be part 1 of a two-part Recall series. In the first part of this two-part recall, Dr. Tesha Monteith begins with a discussion on the highlights of the 2023 International Headache Conference with Drs. Hayrunnisa Bolay, KC Brennan, and Gianluca Coppola. The episode continues with Dr. Stephanie Nahas discussing commonly missed and lesser-known primary headache disorders. Finally, the episode concludes with an interview with Drs. Deb Friedman and Kathleen Digre, who talk about the diagnosis and management of IIH and other CSF pressure disorders.
Related Podcast Links:
https://directory.libsyn.com/episode/index/id/28479644
https://directory.libsyn.com/episode/index/id/28567413
https://directory.libsyn.com/episode/index/id/28675078
Disclosures can be found at Neurology.org
Dr. Shuvro Roy talks with Dr. Monica T. Ly about brain lesions in former football players linked to vascular brain changes.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Cecilia Hvitfeldt Fuglsang about the effects of migraine and PIH on the risk of stroke and myocardial infarction.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Deanna Saylor talks with Prof. Mayowa Owolabi about reducing the global burden of stroke.
Read the related article in Lancet Neurology.
Dr. Halley Alexander talks with Dr. Genna Waldman about her presentation at the AES (Annual Epilepsy Society) symposium session reviewing PNEE (psychogenic non-epileptic events) and indications of discontinuation of medications.
Articles referenced in the episode: https://doi.org/10.1111/epi.12356
https://www.sciencedirect.com/science/article/pii/S1059131119300342
https://onlinelibrary.wiley.com/doi/epdf/10.1002/brb3.2567
https://doi.org/10.1111/j.1528-1167.2010.02696.x
https://doi.org/10.1016/j.yebeh.2021.108004
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Geoff Ling about his thoughts on rapid-fire mortar shooting and more broadly, how he goes about identifying what veterans have been exposed to and treating veterans in the clinic.
They also discussed a little bit about a recently published article in the New York Times titled, "A Secret War, Strange New Wounds, and Silence from the Pentagon."
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Elsmarieke van de Giessen and Emma Coomans about a newly FDA-approved tau-binding radiotracer [18F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired patients assessed for Alzheimer disease.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Prof. Mike Lunn about the relationship between COVID-19 vaccinations and Guillain-Barré syndrome using the National Immunoglobulin Database.
Read the related article in Brain.
Disclosures can be found at Neurology.org.
Dr. Derek Stitt talks with Dr. Ali A. Habib about trends in hospital admissions and in-hospital mortality for adult patients with MG.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Benjamin N. Rome about ways to improve pharmacy benefit managers and the way they function in the system.
Read the related article in The New England Journal of Medicine.
Referenced in this Episode:
June 2021 Neurology Recall Episode
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Dr. Haya Bishara about the association between GBS and both SARS-CoV-2 infection and the COVID-19 vaccine.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
The January 2024 replay starts the new year off with four previously posted episodes on dementia. The episode begins with an interview with Dr. Kenneth Langa on the prevalence of dementia and mild cognitive impairment in the US. The episode continues with an interview with Dr. Beau Ances about the burden amyloid has on individuals with Down syndrome compared to autosomal dominant Alzheimer disease. The next interview is with Dr. Erik Musiek on the use of lecanemab in early Alzheimer disease. The fourth and final interview is with Dr. Vijay Ramanan on the eligibility for anti-amyloid treatment.
Related Podcast Links:
Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the United States: https://directory.libsyn.com/episode/index/id/25811241
Comparison of Amyloid Burden in Individuals with Down Syndrome Versus Autosomal Dominant Alzheimer Disease: https://directory.libsyn.com/episode/index/id/25881414
Lecanemab in Early Alzheimer Disease: https://directory.libsyn.com/episode/index/id/25428333
Eligibility for Anti-Amyloid Treatment: https://directory.libsyn.com/episode/index/id/28300052
Related Article Links:
Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: https://jamanetwork.com/journals/jamaneurology/article-abstract/2797274?resultClick=1
Comparison of Amyloid Burden in Individuals with Down Syndrome Versus Autosomal Dominant Alzheimer's Disease: A Cross-Sectional Study: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00408-2/fulltext
Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging: https://www.neurology.org/doi/10.1212/WNL.0000000000207770
Disclosures can be found at Neurology.org
Dr. Jeff Ratliff talks with Drs. Divya Singhal and Myriam Abdennadher about work-life, parenting, and the well-being of neurologists during the COVID-19 pandemic.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Andrew Southerland talks with Dr. Franzi Herpich about her journey of experiencing a stroke in 2021 as part of our physician-as-patient series.
Previously Posted Content:
April 2022 Neurology Recall: Physician as Patient
Disclosures can be found at Neurology.org.
Dr. Adam de Havenon talks with Dr. Gustaf Edgren about the potential transmissible risk associated with some types of spontaneous intracerebral hemorrhage in patients who receive transfusions.
Read the related article in JAMA.
Disclosures can be found at Neurology.org.
Dr. Elizabeth Coon talks with Dr. Mitchell G. Miglis about the frequency of orthostatic hypotension in isolated REM sleep behavior disorder.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Drs. Michael Fox and Jacob Stubbs about their study on brain network associations in substance use disorders.
Read the related article in Nature.
Disclosures can be found at Neurology.org.
Dr. Farrah Mateen talks with Sumaira Ahmed about The Sumaira Foundation and their global ambassador program for patient advocacy.
Learn more about The Sumaira Foundation.
Disclosures can be found at Neurology.org
Dr. Gordon Smith talks with Laynie Dratch about integrating genetic testing into patient care for persons with Amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) spectrum disorders.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org
Dr. Andy Southerland talks with Dr. Jonathan Coutinho about the accuracy of using EEG in the detection of large vessel occlusion stroke in prehospital settings.
Read the related article in Neurology.
Disclosures can be found at Neurology.org
The December 2023 replay wraps up the year with four previously posted episodes on neurocritical care. The episode begins with an interview with Dr. Karin Diserens on subtle clinical signs in unresponsive brain-impaired individuals. The episode continues with an interview with Dr. David Greer on updated brain death guidelines. The next interview is with Dr. Monica Lemmon on communicating information about neurologic prognosis. The fourth and final interview is with Drs. Susanne Muehlschlegel and Adeline Goss on the prognostic language used in critical neurologic illness.
Related Podcast Links:
Subtle Clinical Signs in Unresponsive Brain Impairment: https://directory.libsyn.com/episode/index/id/27124839
Updated Pediatric and Adult BD/DNC Consensus Guidelines: https://directory.libsyn.com/episode/index/id/28537073
A Parent-Informed Approach to Communicating Neurologic Prognosis in Infants: https://directory.libsyn.com/episode/index/id/25988781
Language Use in Neurocritical Illness Prognostication: https://directory.libsyn.com/episode/index/id/28137575
Related Article Links:
A Focus on Subtle Signs and Motor Behavior to Unveil Awareness in Unresponsive Brain-Impaired Patients: The Importance of Being Clinical: https://doi.org/10.1212/WNL.0000000000207067
Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM: https://doi.org/10.1212/WNL.0000000000207740
The ALIGN Framework: A Parent-Informed Approach to Prognostic Communication for Infants With Neurologic Conditions: https://doi.org/10.1212/WNL.0000000000201600
Prognostic Language in Critical Neurologic Illness: A Multicenter Mixed-Methods Study: https://doi.org/10.1212/WNL.0000000000207462
Disclosures can be found at Neurology.org
Our 2023 November Headache series wraps up with Dr. Tesha Monteith talking with Dr. Stewart Tepper about rapid developments in neuromodulation.
Disclosures can be found at Neurology.org
Dr. Tesha Monteith talks with Dr. Peter Goadsby about updates on migraine treatments and the integration of CGRP inhibitors into clinical practice.
Disclosures can be found at Neurology.org
Dr. Tesha Monteith talks with Dr. Messoud Ashina about the mechanisms of migraine.
Articles Referenced in this Episode:
Disclosures can be found at Neurology.org
Dr. Andrew Southerland talks with Dr. Seemant Chaturvedi about exciting new trials that have come out in the world of stroke that were presented at this year's World Stroke Congress.
Read more on the World Stroke Congress page.
Disclosures can be found at Neurology.org
Dr. Tesha Monteith talks with Drs. Deb Friedman and Kathleen Digre about the diagnosis and management of idiopathic intracranial hypertension and cerebrospinal fluid pressure disorders.
Disclosures can be found at Neurology.org
Dr. Farrah Mateen talks with Dr. Teddy Totimeh about the urgent need to improve/develop existing and nonexistent neuro-oncology infrastructure, personnel, and logistics across borders.
Read the related article in World Neurosurgery.
Disclosures can be found at Neurology.org
Dr. Tesha Monteith talks with Dr. Stephanie Nahas about commonly missed and lesser-known primary headache disorders.
Disclosures can be found at Neurology.org
Dr. Halley Alexander talks with Dr. David Greer about updating and clarifying the brain death/death by neurologic criteria guidelines for adult and pediatric patients.
Read the related article in Neurology.
Visit NPub.org/Podcast for associated article links.
Disclosures can be found at Neurology.org
Dr. Tesha Monteith talks with Drs. Hayrunnisa Bolay, KC Brennan, and Gianluca Coppola about the International Headache Conference that took place in September and clinical advances in headache medicine.
Read more about the 2023 IHC.
Disclosures can be found at Neurology.org
The November 2023 replay of past episodes showcases five interviews on topics in stroke. The episode begins with an interview with Dr. Imogene Scott on prehospital telestroke vs paramedic scores to accurately identify stroke reperfusion candidates. The episode continues with an interview with Dr. David Seiffge on the use of oral anticoagulants on ischemic stroke. The next interview is with Dr. Alejandro Rabinstein and Hassan Kobeissi on comparing outcomes between CTP and NCCT for endovascular therapy selection in the late therapeutic window. The fourth interview is with Dr. Thanh Nguyen discussing whether dual antiplatelet therapy is non-inferior to intravenous thrombolysis among patients with minor non-disabling acute ischemic stroke. The November Recall concludes with Dr. Seemant Chaturvedi discussing this year's European Stroke Organization Conference and pivotal trials that were presented during the conference.
Related Podcast Links:
Pre-Hospital Evaluation of Acute Stroke: EMS vs Telemed: https://directory.libsyn.com/episode/index/id/24928863
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants: https://directory.libsyn.com/episode/index/id/25736865
CT Perfusion vs CT for Late Window Stroke Thrombectomy: https://directory.libsyn.com/episode/index/id/26673237
Dual Antiplatelet Therapy vs Alteplase for Patients With Acute Ischemic Stroke: https://directory.libsyn.com/episode/index/id/27455412
Pivotal Stroke Trials Presented at this Year’s ESOC: https://directory.libsyn.com/episode/index/id/27279144
Related Article Links:
Prehospital Telestroke vs Paramedic Scores to Accurately Identify Stroke Reperfusion Candidates: A Cluster Randomized Controlled Trial: https://n.neurology.org/content/99/19/e2125
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants: https://jamanetwork.com/journals/jamaneurology/fullarticle/2799622
CT Perfusion vs Noncontrast CT for Late Window Stroke Thrombectomy: A Systematic Review and Meta-analysis: https://n.neurology.org/content/100/22/e2304
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial: https://jamanetwork.com/journals/jama/article-abstract/2806532
ESOC Plenary: https://2023.eso-conference.org/programme/plenary-highlights/
Disclosures can be found at Neurology.org
Dr. Stacey Clardy talks with Drs. Brian Stamm and Behnam Sabayan about the spectrum of clinical presentations, neuroimaging patterns, and the predictors of radiographic and clinical outcomes from diffusion-restricted splenial lesions.
Read the related article in Neurology: Clinical Practice.
Visit NPub.org/Podcast for associated article links.
Disclosures can be found at Neurology.org
Dr. Jeff Burns talks with Dr. Natalia Rost about the AAN's brain health initiative.
Read the related article in Neurology.
Visit NPub.org/Podcast for associated article links.
Dr. Jennifer Majersik talks with Samantha Cote about the relationship between lifetime hormone exposure and cerebral small vessel disease in postmenopausal women in the UK-Biobank.
Read the related article in Neurology.
Visit NPub.org/Podcast for associated article links.
Dr. Kait Nevel talks with Dr. Philipp Karschnia about the assessment on whether MTHFR polymorphisms affects the risk for leukoencephalopathy.
Read the related article in Neurology.
Visit NPub.org/Podcast for associated article links.
Dr. Jeff Ratliff talks with Dr. Gregg Day about the adaption of the STAM3P screening scores in clinical practice to minimize diagnosis delays and missed opportunities for treatment in patients with suspected rapidly progressive dementia.
Read the related article in Annals of Neurology.
Visit NPub.org/Podcast for associated article links.
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment.
Read the related article in Neurology.
Visit NPub.org/Podcast for associated article links.
Dr. Andy Southerland talks with Dr. Christine Mc Carthy about the connection between sleep disturbance symptoms and the risk of acute stroke.
Read the related article in Neurology.
Visit NPub.org/Podcast for associated article links.
Dr. Halley Alexander talks with Dr. Sándor Beniczky about the use of artificial intelligence to accurately interpret routine clinical electroencephalograms.
Read the related article in JAMA Neurology.
Visit NPub.org/Podcast for associated article links.
Dr. Alex Menze talks with Dr. Marianne Chanti-Ketterl about the association between traumatic brain injury and cognitive decline among older veteran men.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
The October Neurology Recall highlights Dr. Justin Abbatemarco’s four-part series on autoimmune encephalitis from August 2023. The episode begins with Dr. Josep Dalmau discussing relevant updates and ongoing/upcoming research around autoimmune encephalitis. The next episode discusses the practical approach to testing for auto antibodies in autoimmune encephalitis with Drs. Drs. Sarosh Irani and John Soltys. The episode continues with Drs. Eoin Flanagan and Grace Gombolay helping expand the differential diagnosis in autoimmune encephalitis cases. The October Recall concludes with Dr. Maarten Titulaer talking about the importance of longitudinal care for patients with autoimmune encephalitis.
Related Links:
Autoimmune Encephalitis Series: Advancing the Science Trials in ALS - https://directory.libsyn.com/episode/index/id/27682701 Autoimmune Encephalitis Series: A Rationale Approach to Diagnostics and Interpretation - https://directory.libsyn.com/episode/index/id/27712707 Autoimmune Encephalitis Series: Expanding the Differential - https://directory.libsyn.com/episode/index/id/27747390 Autoimmune Encephalitis Series: The Importance of Longitudinal Care - https://directory.libsyn.com/episode/index/id/27901296
Dr. Andy Southerland talks with Dr. Brian Callaghan about patient travel distance and travel time to neurologist visits, across neurologic conditions and subspecialties.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
Dr. Neha Dangayach talks with Drs. Susanne Muehlschlegel and Adeline Goss about characterizing the prognostic language clinicians use in critical neurologic illness.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
Dr. Derek Stitt talks with Prof. Clemens Warnke about the clinical presentation of progressive multifocal leukoencephalopathy, its variants, pathogenesis, and current diagnostic approaches.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
Dr. Farrah Mateen talks with Dr. Richard Benson about the NINDS health equity efforts and the implications of the new strategic plan for research.
Read the related supplement in Neurology.
Visit NPUb.org/Podcast for associated article links.
In the last episode of our three-part series, Prof. Jon Stone talks with Drs. Selma Aybek, David Perez, and Sarah Lidstone about diagnosis and treatment for FND.
Related Links:
FND Society at fndsociety.org
FND guide for patients at neurosymptoms.org
FND Hope at fndhope.org
Visit NPUb.org/Podcast for associated article links.
Dr. Matt Barrett talks with Drs. Julie A. Schneider and Sonal Agrawal about whether Lewy body and cerebrovascular pathologies act synergistically to increase the severity of parkinsonism beyond their separate effects.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
Dr. Jessica Ailani talks with Dr. Aaron Kesselheim and Leigh Sharpless about the endpoints used in trials supporting the US FDA approval of medications treating migraines.
Read the related article in Neurology.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Dr. Alexander Menze talks with Dr. Brooke Conway Kleven about the association between a clinical diagnosis of traumatic encephalopathy syndrome and subsequent temporal decline in cognitive or MRI volumetric measures.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
The September 2023 Neurology Recall showcases five dynamic interviews about ALS. The episode begins with a discussion about the strategic plan for ALS from the NINDS with Dr. Walter Korshetz. This episode features conversations with Drs. Ruben P.A. van Eijk-3 and Jordi van Unnik on simulation based interim analysis of ALS clinical trials followed by an interview with Dr. Emily Plowman on respiratory strength training (RST) programs in individuals with ALS. The episode continues with an interview with Dr. Suma Babu on the approved treatment for ALS associated with a mutation in the SOD1 gene. This month's Recall concludes with a conversation with Dr. Ajay Sampat on his story of being a neurologist diagnosed with ALS.
Related Articles:
Related Podcast:
Visit NPUb.org/Podcast for associated article links.
Disclosures can be found at Neurology.org.
In the fourth episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Dr. Maarten Titulaer about the importance of longitudinal care for autoimmune encephalitis.
Visit NPUb.org/Podcast for additional podcasts and associated article links.
Disclosures can be found at Neurology.org.
In the second episode of our three-part series, Prof. Jon Stone talks with Drs. Selma Aybek, David Perez, and Sarah Lidstone about how and why FND occurs.
Related Links:
Visit NPUb.org/Podcast for associated article links.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Wouter Schievink about what spontaneous intracranial hypotension is and why it's commonly misdiagnosed.
Visit NPUb.org/Podcast for additional podcasts and associated article links.
Dr. Jason Crowell talks with Dr. Frederic Schaper about lesion-related epilepsy mapping to specific brain networks.
Read the related article in JAMA Neurology.
Visit NPUb.org/Podcast for additional podcasts and associated article links.
Dr. Gordon Smith talks with Dr. Ajay Sampat about his journey of being a neurologist and getting diagnosed with ALS at 36.
Visit NPUb.org/Podcast for additional podcasts and associated article links.
In the third episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Drs. Eoin Flanagan and Grace Gombolay about a practical approach to testing for auto antibodies and autoimmune encephalitis.
Visit NPUb.org/Podcast for additional podcasts and associated article links.
In the second episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Drs. Sarosh Irani and John Soltys about a practical approach to testing for auto antibodies and autoimmune encephalitis.
Visit NPUb.org/Podcast for additional podcasts and associated article links.
In the first episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Dr. Josep Dalmau about relevant updates on autoimmune encephalitis, ongoing/upcoming clinical trials, and so much more.
Visit NPUb.org/Podcast for additional podcasts and associated article links.
In this first episode of our three-part series, Prof. Jon Stone talks with Drs. Selma Aybek, David Perez, and Sarah Lidstone about FND diagnosis and exploring new phenotypes.
Related Links:
Visit NPUb.org/Podcast for associated article links.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
The August 2023 replay of past episodes showcases four interviews on functional neurologic disorders with Prof. Jon Stone. The episode begins with an interview by Prof. Jon Stone and Dr. Tamara Pringsheim with Wall Street Journal columnist Julie Jargon about the increased incidence of teen girls presenting with physical tics. The Recall episode continues with an interview with Drs. Tamara Pringsheim and Davide Martino about the latest updates on those functional tics and new diagnostic criteria. The third interview is with Dr. Tjerk Lagrand about how the diagnosis of functional seizures affects health care costs. The August Recall concludes with Dr. Mahinda Yogarajah about the importance of diagnosing and not misdiagnosing functional neurologic disorders.
Related Podcast Links:
Related Article Links:
Dr. Stacey Clardy talks with Dr. Natalia Rost about her experience speaking before the House of Representatives on the approval of lecanemab for the treatment of early Alzheimer disease.
Visit NPUb.org/Podcast for associated article links.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Dr. Justin Abbatemarco talks with Dr. Amel Karaa about the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
Dr. Gordon Smith talks with Dr. Hoda Abdel-Hamid about the recent FDA approval for the first ever gene therapy for Duchenne muscular dystrophy.
Visit NPUb.org/Podcast for associated article links.
Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas.
Read the related article in The New England Journal of Medicine.
Visit NPUb.org/Podcast for associated article links.
Dr. Jason Crowell talks with Prof. Jacob Elberg to provide neurologists with an insight into what goes on behind the scenes for patient-assistance programs.
Read the related article in The New England Journal of Medicine.
Visit NPUb.org/Podcast for associated article links.
Dr. Dan Ackerman talks with Dr. Thanh Nguyen about whether dual antiplatelet therapy is noninferior to intravenous thrombolysis among patients with minor nondisabling acute ischemic stroke.
Read the related article in JAMA.
Visit NPUb.org/Podcast for associated article links.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Dr. Stacey Clardy talks with Dr. Jonathan Graff-Radford about everything we need to know about corticobasal syndrome.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Dr. Gordon Smith talks with Drs. Ruben P.A. van Eijk and Jordi van Unnik about the planning of interim analyses for clinical trials in ALS to maximize patient safety and minimize exposure to ineffective or harmful drugs.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
Dr. Justin Abbatemarco talks with Dr. Bart Jacobs about cerebrospinal fluid findings in relation to clinical and electrodiagnostic subtypes, severity, and outcome of Guillain-Barré syndrome.
Read the related article in Neurology.
Visit NPUb.org/Podcast for associated article links.
The July 2023 replay of past episodes showcases five interviews on social determinants of health in neurology. The episode begins with an interview with Dr. Heather Leeper on the links between pain and depression with unemployment due to CNS cancer. The episode continues with an interview with Dr. Wyatt Bensken on racial and ethnic difference in antiseizure medication prescription. The next interview is with Dr. Scott Mendelson on race-ethnic disparities in stroke thrombolysis. The fourth interview is with Dr. Vikas Kotagal on neighborhood socioeconomic factors in people with various movement disorders. The final episode is with Dr. Daniel Di Luca on racial and ethnic differences in quality of life among people with Parkinson’s disease.
Related Podcast Links:
Related Article Links:
Visit NPUb.org/Podcast for associated article links
Dr. Tesha Monteith talks with Dr. Andrew Charles about new updates in the field of migraine following the American Headache Society conference in honor of National Migraine and Headache Awareness Month.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about this year's European Stroke Organization Conference and pivotal trials that were presented during the conference.
Read the related content on the ESOC Plenary Highlights page.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Prof. Jon Stone talks with Dr. Mahinda Yogarajah about the importance of diagnosing and not misdiagnosing functional neurologic disorders.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Daniel Garbin Di Luca about racial and ethnic differences in health-related quality of life for individuals with Parkinson disease.
Read the related article in Neurology.
For links to articles and previous podcast episodes, please visit NPUb.org/Podcast. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Special Episode - Neurology Podcast: Dr. Farrah Mateen talked with Dr. Martin A. Samuels for the living legends series back in 2013. Listen to this previously posted episode in memory of Dr. Samuels.
For links to articles and previous podcast episodes, please visit NPUb.org/Podcast.
Find the link to the original episode here: https://directory.libsyn.com/episode/index/id/8128592
Dr. Tesha Monteith talks with Dr. Messoud Ashina about a ten-step approach for the diagnosis and management of migraines in various patient populations.
Read the related article in Nature Review Neurology.
For links to articles and previous podcast episodes, please visit NPUb.org/Podcast.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Derek Stitt talks with Dr. Karin Diserens about subtle signs and motor behavior to unveil awareness in unresponsive brain-impaired individuals.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org
Dr. Gregg Day talks with Prof. Ronald Postuma about the conflicting evidence regarding the association between seasonal changes and daylight-saving time and sleep disorders. Read the related article in Neurology.
For links to articles and previous podcast episodes, please visit NPUb.org/Podcast.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Derek Stitt talks with Dr. Andrew Callen about the relationship between bern score, spinal elastance, and opening pressure in patients with spontaneous intracranial hypotension.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
The June 2023 replay of past episodes showcases a selection of interviews regarding the biomarker discovery in Parkinson disease. This episode begins with an overview of the latest in Parkinson’s research, including biomarker development with Dr. Bas Bloom. The episode continues with an interview with Dr. Lucilla Parnetti about the clinical application of α-synuclein seed amplification, leading into an interview with Prof. Andrew Siderowf about seed amplification in PD in the PPMI cohort. The June Neurology Recall concludes with an interview with Dr. Christopher Gibbons on skin α-synuclein in MSA and PD.
Related Podcast Links:
Biomarker and Treatment Development in Movement Disorders: https://directory.libsyn.com/episode/index/id/26775207
Alpha-synuclein Amplification for Disease Diagnosis: https://directory.libsyn.com/episode/index/id/23923047
α-Synuclein Seed Amplification in a Large Parkinson Cohort: https://directory.libsyn.com/episode/index/id/26961315
Skin α-Synuclein In MSA and PD: https://directory.libsyn.com/episode/index/id/26499948
Related Article Links:
Research in Movement Disorders in 2022: A New Era of Biomarker and Treatment Development: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00494-X/fulltex
Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward: https://n.neurology.org/content/99/5/195
Assessment of Heterogeneity Among Participants in the Parkinson's Progression Markers Initiative Cohort Using _-Synuclein Seed Amplification: A Cross-Sectional Study: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00109-6/fulltext
Cutaneous _-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease: https://n.neurology.org/content/100/15/e1529
Disclosures can be found at Neurology.org
Dr. Alison Christy talks with Dr. Tatjana Bremova-Ertl about the use of N-acetyl-L-leucine in pediatric and adult patients with GM2 gangliosidoses.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Prof. Andrew Siderowf about the assessment of heterogeneity among participants in the Parkinson progression markers initiative cohort using α-synuclein seed amplification.
Read the related article in The Lancet Neurology.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Nico Dosenbach about topographic brain organization and redrawing the homunculus.
Read the related article in Nature.
Disclosures can be found at Neurology.org.
Dr. Farrah Mateen talks with Dr. Deanna Saylor about proposed competencies that can serve as a basis for global neurology training programs.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Read the related article on the FDA website.
Disclosures can be found at Neurology.org
Dr. Jason Crowell talks with Dr. Farrah Mateen about clinical information that neurologists and other clinicians can use to treat people who are forcibly displaced.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Prof. Bastiaan Bloem about the latest developments in biomarkers and treatments for movement disorders, which have been described in numerous research papers from 2022.
Read the related article in The Lancet.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Mark Burish about circadian-targeted research into cluster headaches and migraines.
Read the related article in Neurology.
Disclosures can be found at Neurology.org
Dr. Jason Crowell talks with Dr. Sophie Cho, Program Director in the Division of Clinical Research at NINDS, about the state of Parkinson disease research.
For links to previous podcast episodes, please visit NPUb.org/Podcast.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Raúl Martínez-Fernández about the long-term outcome of unilateral FUS-STN treatment for Parkinson disease.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Cost Burden of MS in the US: Retinal and Cortical Atrophy in MS: Association of EBV and Multiple Sclerosis https://directory.libsyn.com/episode/index/id/22394066
https://directory.libsyn.com/episode/index/id/25428246
https://directory.libsyn.com/episode/index/id/26217204
The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs: https://n.neurology.org/content/98/18/e1810
Efficacy of Diet on Fatigue and Quality of Life in Multiple Sclerosis: A Systematic Review and Network Meta-analysis of Randomized Trials: https://n.neurology.org/content/100/4/e357
Dr. Andrew Southerland talks with Dr. Alejandro Rabinstein and Hassan Kobeissi about comparing outcomes between CTP and NCCT for EVT selection in the late therapeutic window.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Matthew Harms talks with Dr. Emily Plowman about the effects of inspiratory and expiratory respiratory strength training (RST) programs in individuals with ALS.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Prof. Jon Stone speaks with Drs. Tamara Pringsheim and Davide Martino about the latest updates on functional tic-like behaviors and new diagnostic criteria.
For more information on this topic, check out the previous conversation from January 2022 with Prof. Jon Stone and Dr. Tamara Pringsheim.
Read the related article in The New York Times.
Read the other related articles in the European Journal of Neurology by Dr. Martino and Dr. Pringsheim.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Alexandra Jean Sinclair about disease course and long-term outcomes in pregnant women with idiopathic intracranial hypertension.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Vikas Kotagal about how neighborhood socioeconomic factors vary among individuals with different types of clinical movement disorders.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. Christopher Gibbons about the need for accurate diagnostic and prognostic biomarkers for MSA and its differentiation from other synucleinopathies.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Jason Crowell talks with Dr. David Lynch about the use of omaveloxolone for patients with friedreich ataxia.
Read the related article in Annuals of Neurology.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Martin Underwood about supportive self-management programs for people living with chronic migraines or chronic tension-type headaches with episodic migraines.
Read the related article in Neurology.
Disclosures can be found at Neurology.org
The April 2023 replay of past episodes showcases our November 2022 headache series hosted by Dr. Tesha Monteith. The first episode features a conversation with Dr. Peter Goadsby about the value offered by headache classifications, followed by an interview with Drs. Simona Sacco and Jessica Ailani about an update on migraine guidelines. Next in the episode, Dr. Lars Edvinsson discusses CGRP and the role of sex hormones. The April recall closes out with an interview with Dr. Rebecca Burch about hot topics in headache medicine.
Related Podcast Links:
November Headache Series: Increasing the Value of Neurology Through Headache Classifications: http://directory.libsyn.com/episode/index/id/24894771
November Headache Series: Update on Migraine Guidelines: https://directory.libsyn.com/episode/index/id/25083906
November Headache Series: CGRP and Role of Sex Hormones: https://directory.libsyn.com/episode/index/id/24967986
November Headache Series: Hot Topics in Headache Medicine: https://directory.libsyn.com/episode/index/id/25042293
Disclosures can be found at Neurology.org
This episode features Dr. Stacey Clardy in conversation with the 2023 Ted Burns Humanism in Neurology Award winner, Dr. Deanna Saylor.
Disclosures can be found at Neurology.org.
Read the related article in Neurology.
In this episode, dedicated to the memory of the 35th president of the AAN, Dr. Ralph Sacco, Dr. Tesha Monteith talks with Dr. Mitch Elkind and Dr. Orly Avitzur, as they talk about the life, legacy, and incredible achievements of Dr. Ralph Sacco for all that he touched and for those left to be inspired.
Read Dr. Sacco's In Memoriam article.
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Anto Bagic about the utilization of specific surgical techniques for epilepsy from the National Association of Epilepsy Centers.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Read the related article in JAMA Neurology.
Dr. Shuvro Roy talks with Dr. Matilde Inglese about comparing stem-cell transplants to DMTs in patients with Secondary Progressive MS.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Michel Ferrari about the lessons from the first gene to novel targets and mechanisms of migraines.
Read the related article in PubMed.
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Dr. Vera Bril about exploring the potential use of immunoglobulin as a corticosteroid-sparing agent in patients with Myasthenia Gravis.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Kathryn Nevel talks with Dr. Linda Liau about the use of autologous tumor lysate-loaded dendritic cell vaccination for the treatment of newly diagnosed and recurrent glioblastoma.
Read the related article in JAMA Oncology.
Disclosures can be found at Neurology.org.
Dr. Shuvro Roy talks with Dr. Sara Mariotto about the importance of myelin oligodendrocyte glycoprotein antibodies in CSF.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Dr. Peter Van Den Bergh about updated guidelines prepared under the auspices of the PNS and EAN on CIDP.
Read the related articles published in each of their respective journals.
Disclosures can be found at Neurology.org.
Dr. Maisha Robinson talks with Dr. Monica Lemmon about a framework to guide clinicians in communicating information about neurologic prognosis.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Matthew Robbins about guidelines for cluster headaches, an update on treatment opinions, and so much more.
Read the related article mentioned in JAMA Neurology.
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Wyatt Bensken about the difference in antiseizure medications between racial and ethnic groups among people with epilepsy.
Read the related article in Neurology: Clinical Practice.
Disclosures can be found at Neurology.org.
Read the related article in The Lancet Neurology.
Dr. Jessica Ailani talks with Dr. Katharina Wolf, about MRI of CSF-flow and spinal cord motion being a promising diagnostic tool in SIH.
Read the full article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Roy Hamilton talks with Dr. Kenneth Langa, about the prevalence of dementia and mild cognitive impairment in the US.
Read the full article in JAMA Neurology.
This episode is brought to you by Mass General Brigham Department of Neurology, please visit us at www.massgeneralbrigham.org.
Disclosures can be found at Neurology.org.
The February 2023 Neurology Recall showcases four dynamic interviews about Pre-Symptomatic Findings in Neurodegeneration. This episode features conversations with Dr. Sana Aslam on the clinicopathologic correlations of jaw tremor, followed by an interview with Dr. Valeria Iodice on diagnosing pre-motor multiple system atrophy, leading into an interview with Dr. Joe Verghese on olfactory dysfunction and incidence of motoric cognitive risk syndrome. This month's Recall concludes with a conversation with Dr. Rafael Romero on the correlation between perivascular spaces visible on MRIs and the risk of incident dementia.
Related Podcast Links:
Clinicopathologic Correlations of Jaw Tremor: https://directory.libsyn.com/episode/index/id/24745884
Diagnosing Pre-Motor Multiple System Atrophy: https://directory.libsyn.com/episode/index/id/24643809
Olfactory Dysfunction and Motoric Cognitive Risk: https://directory.libsyn.com/episode/index/id/24781977
MRI Visible Perivascular Spaces and Risk of Incident Dementia: The Framingham Heart Study: https://directory.libsyn.com/episode/index/id/25304007
Related Articles Links:
Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study: https://doi.org/10.1212/CPJ.0000000000200072
Diagnosing Premotor Multiple System Atrophy Natural History and Autonomic Testing in an Autopsy-Confirmed Cohort: https://doi.org/10.1212/WNL.0000000000200861
Olfactory Dysfunction and Incidence of Motoric Cognitive Risk Syndrome A Prospective Clinical-Pathologic Study: https://doi.org/10.1212/WNL.0000000000201030
MRI-Visible Perivascular Spaces and Risk of Incident Dementia The Framingham Heart Study: https://doi.org/10.1212/WNL.0000000000201293
Disclosures can be found at Neurology.org
Dr. Justin Abbatemarco talks with Dr. Mark Gorman, about primary angiitis of the CNS.
Read the full article in Annals of Neurology.
This episode is brought to you by Mass General Brigham Department of Neurology, please visit us at www.massgeneralbrigham.org.
Disclosures can be found at Neurology.org.
Dr. Dan Ackerman talks with Dr. David Seiffge about the use of oral anticoagulants on ischemic stroke.
Read the full article in JAMA Neurology.
This episode is brought to you by Mass General Brigham Department of Neurology, please visit us at www.massgeneralbrigham.org.
Disclosures can be found at Neurology.org.
Dr. Gregg Day talks with Dr. Jane Alty, about the effect of cognitive reserve on cognitive decline in men and women as they age.
Read the full article in Neurology.
This podcast is sponsored by Mass General Hospital. Visit https://www.massgeneral.org/ for more information.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with columnist Stephen Marche, about the evolving topic of natural language processing and its impact on neurology and everyday life.
Read the full article in The Atlantic.
Disclosures can be found at Neurology.org.
Dr. Jon Stone talks with Dr. Tjerk Lagrand, about how the diagnosis of functional seizures affects health care costs.
Disclosures can be found at Neurology.org.
Dr. Derek Stitt talks with Dr. Rachna Malani, about the potential neurotoxicity associated with CAR-T therapy.
Disclosures can be found at Neurology.org.
Dr. Holly Hinson talks with Dr. Deborah Hall, about gender disparities among neurology researchers.
Read the full article in Neurology.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Kathleen Digre, about neuro-ophthalmology, treatments for photophobia, and so much more.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Juliana VanderPluym, about the incidence, recurrence and clinical association of status migrainosus in Olmsted County Minnesota.
Read the full article in Neurology.
Disclosures can be found at Neurology.org.
The January 2023 replay of past episodes showcases a selection of interviews covering a variety of topics in Autoimmune Neurologic Disorders. This episode features conversations with Dr. Marinos Dalakas on IVIg efficacy in GAD65 positive SPS patients , followed by an interview with Prof. Bart Jacobs about the association of preceding infections with the clinical variation of Guillain-Barré syndrome across geographical regions, leading into an interview with Prof. Sarosh Irani on the use of corticosteroids as a first-line agent in the treatment of LGI1-antibody encephalitis. January's Neurology Recall concludes with an interview with Dr. Ming Lim on the diagnosis and management of Opsoclonus Myoclonus Ataxia Syndrome (OMAS) in children.
Associated Articles:
An International Perspective on Preceding Infections in Guillain-Barré Syndrome | Neurology
Disclosures can be found at Neurology.org.
Dr. Gregg Day talks with Dr. Erik Musiek, about the use of lecanemab in early Alzheimer disease.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemacro talks with Dr. Tyler Titcomb, registered dietitian from the University of Iowa, about the role diet plays on multiple sclerosis care.
Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemacro talks with Dr. Eoin Flanagan about the misdiagnosis of autoimmune encephalitis.
Read the related article in JAMA Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Rob de Bie about the effects of levodopa in patients with early Parkinson disease.
Dr. Jason Crowell talks with Prof. Haydeh Payami, Professor of Neurology and Genetics at the University of Alabama at Birmingham, about how the gut microbiome may play a role in Parkinson disease according to metagenomics.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Gordon Smith talks with Dr. Fredrik Piehl about the use of rituximab for new-onset generalized myasthenia gravis.
Read the related article in JAMA Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Leah Blank about interfacility transfers for seizure-related emergencies.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Shuvro Roy talks with Dr. Charles Marshall, about the increased risk of suicide following a dementia diagnosis.
Read the related article in JAMA Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Gregg Day from the Mayo Clinic in Jacksonville Florida, about patients with rapidly progressive dementia due to Creutzfeldt-Jakob disease versus other causes.
Read the related article in Neurology: Clinical Practice.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Deanna Saylor talks with Dr. Augustina Charway-Felli, President of the African Academy of Neurology (AFAN), about the African Academy of Neurology and the AFAN Annual Meeting.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Drs. Simona Sacco and Jessica Ailani about migraine guidelines as part of the November Headache Series.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Rebecca Burch about hot topics in headache medicine as part of the November Headache Series.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Lars Edvinsson who is a leading expert in the field of cerebral circulation and migraines. In this episode, they discuss CGRP and the role of sex hormones as part of our November Headache Series.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Dan Ackerman talks with Dr. Imogene Scott about prehospital telestroke vs paramedic scores to accurately identify stroke reperfusion candidates.
Read the related article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Call to Action for Neurologists. On this week's episode, Dr. Tesha Monteith talks with Dr. Peter Goadsby about headache classifications as part of the November Headache Series.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
The November 2022 replay of past episodes showcases four incredible interviews with topics in headache. This episode features conversations with Dr. Todd Schwedt on medicine overuse headaches, followed by an interview with Dr. Eoin Flanagan on brain processing in patients with migraine. The November recall's final two interviews feature discussions about IIH; Dr. Susan Mollan discusses the effects of weight loss in IIH, and then Dr. Tesha Monteith and Prof. Rigmor Højland Jensen discuss psychiatric co-morbidities in IIH.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Alice Chen-Plotkin about how GPNMB confers risk for Parkinson disease through interaction with α-synuclein.
Neurology: Education has launched! In this episode, learn more about Neurology: Education (NE) with NE Editor Dr. Roy Strowd and Deputy Podcast Editor Dr. Jeff Ratliff. Read more about Neurology: Education in this editorial, and visit the Neurology: Education website here: NPub.org/NE.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Jeff Burns talks to Dr. Joe Verghese about olfactory dysfunction and incidence of motoric cognitive risk syndrome, a prospective clinical-pathological study.
Dr. Jeff Ratliff talks with Dr. Sana Aslam about her team's paper on the clinicopathologic correlations of jaw tremor in a longitudinal aging study.
Dr. Justin Abbatemarco talks with Dr. Christian Cordano about differences in age-related retinal and cortical atrophy rates in multiple sclerosis.
Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Ingo Helbig about the use of ketamine for management of neonatal and pediatric refractory status epilepticus.
Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Elizabeth Coon talks with Dr. Valeria Iodice about diagnosing pre-motor multiple system atrophy.
Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Xavier Ayrignac about adult-onset CNS disorders showing as neuroinflammatory disorders.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
The October 2022 replay of past episodes showcases four dynamic interviews about acute stroke. This episode features conversations with Dr. Prachi Mehndiratta on young onset stroke risk in Black and White individuals, followed by an interview with Dr. Scott Mendelson on race and ethnic disparities in stroke thrombolysis, leading into an interview with Dr. Gaspard Gerschenfeld on stroke outcomes using tenecteplace (vs. tPA0 before thrombectomy. October's Neurology Recall concludes with an interview with Dr. Urs Fischer on thrombectomy alone vs. IV alteplase with thrombectomy.
Disclosures can be found at Neurology.org.
Dr. Alex Menze talks with Dr. Jacqueline French and Dr. David Auerbach about the updated research and science behind the neurological and cardiac "sudden death" risks of sodium channel blockers such as Lamotrigine. Dr. French will be joining us for our Fall Conference from Oct 28th-30th, 2022 to discuss other major findings in the Epilepsy community during her workshop "Curbside Consults; Epilepsy".
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Southerland talks with Dr. Carlos Garcia-Esperon about the association of endovascular thrombectomy with functional outcome in patients with acute stroke with a large ischemic core. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Halley Alexander talks with Dr. Johan Koekkoek about the effectiveness of AED duotherapies in patients with glioma. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Justin Abbatemarco talks with Dr. Ken Tyler about CNS infections and next gen sequencing, and ends by touching on the monkeypox virus (MPV), and polio surges.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Dan Ackerman talks with Dr. Jonathan Coutinho about ECG-gated cardiac CT in the acute phase of ischemic stroke vs. thransthoracic echocardiography.
Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Prof. Bart Jacobs about the association of preceding infections with the clinical variation of Guillain-Barré syndrome across geographical regions. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Jessica Ailani talks with Dr. Susan Mollan about the amount of weight loss required to reduce intracranial pressure in patients with idiopathic intracranial hypertension. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Matt Barrett talks with Dr. Philip Tipton about differences in motor features of C9orf72, MAPT, and GRN variant carriers with familial frontotemporal lobar degeneration. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Stacey Clardy talks with Dr. Marinos Dalakas about IVIg efficacy in GAD antibody-positive stiff-person syndrome. Read the full article in Neurology: Neuroimmunology & Neuroinflammation.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
The September 2022 replay of past episodes showcases a selection of interviews about cognitive impairment from less common causes. This episode features dynamic conversations with Dr. Raquel Garnder on cognitive outcomes in TBI, transient global amnesia and TGA recurrence with Dr. Michaela Hernández, and a lesson on COVID Brain Fog and other cognitive syndromes with Dr. Avi Nath from NINDS. This month's Recall concludes with a conversation with Dr. Monica Shieu on PAP therapy and incidence of cognitive disorders in OSA.
Dr. Gregg Day talks with Dr. Adeline Goss about palliative care for inpatients with dementia.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Jason Crowell talks with Dr. Karlo Lizarraga and Dr. Angela Hewitt about neurophysiological biomarkers to optimize deep brain stimulation in movement disorders.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Dan Ackerman talks with Prof. Urs Fischer about the use of thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with acute ischemic stroke.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Gregg Day talks with Dr. Mark Dubbelman about determining clinical meaningfulness in dementia. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Stacey Clardy talks with Dr. W. Oliver Tobin about histiocytic diseases affecting the CNS.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Scott Mintzer talks with Dr. Adithya Sivaraju about predicting outcomes among patients undergoing intracranial EEG. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. B.J. Hicks talks with Dr. Prachi Mehndiratta about the differences in multiple risk factors between Black and White individuals with young-onset ischemic stroke. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Jeff Ratliff talks with Dr. Adrienne Boire about the disordance between perceptions and experience in patients undergoing lumbar puncture. Read the full article in Neurology: Clinical Practice.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Farrah Mateen talks with Dr. Nicoline Schiess about the WHO Brain Health Unit and the Intersectoral Global Action Plan for Epilepsy and Other Neurological Disorders. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Jason Crowell talks with Dr. Lucilla Parnetti about the clinical application of α-synuclein seed amplification assays (SAAs) in the identification of Parkinson disease and other synucleinopathies. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
The August 2022 replay of past episodes showcases recent interviews in the realm of Parkinson disease (PD), with topics ranging from initial clinical management to more advanced methodologies to optimize treatment. This episode features conversations with Dr. Anthony Lang, Dr. Meredith Bock, and Dr. Jan Rusz on dopamine-based therapies in early PD, factors associated with quality of life in PD, and new research on speech impairment subtypes in PD, respectively. The episode concludes with Dr. Michael Fox discussing brain networks and their role in cognitive decline after DBS surgery.
Dr. Jason Crowell talks with Dr. Manu Sharma about the genome-wide association of age-at-onset in Parkinson disease. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Stacey Clardy talks with Dr. Micaela Hernández about transient global amnesia and the prevalence and risk factors of relapse. Read the full article in Neurology: Clinical Practice.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Derek Stitt talks with Dr. Monica Shieu about the impact of positive airway pressure (PAP) therapy on incidence of cognitive disorders and decline among adults with obstructive sleep apnea (OSA). Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Gregg Day talks with Prof. Barbara Sahakian about the associations of social isolation and loneliness with later dementia. Read the full article in Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Dr. Tesha Monteith talks with Prof. Rigmor Højland Jensen about psychiatric co-morbidities in patients with idiopathic intracranial hypertension. Read the full article in Neurology.
Dr. Stacey Clardy talks with Kelsey Wiggs Karlan about whether children born to women who use serotonergic antidepressants during pregnancy have higher risk of neonatal seizures and epilepsy. Read the full article in Neurology.
In this episode dedicated to the memory of Neurology Podcast Founder Dr. Ted Burns, Dr. Jeff Ratliff narrates a compilation of excerpts from a previously recorded discussion between Dr. Stacey Clardy and Ted Burns in 2021 about Ted’s journey with the podcast and his impact on neurology education.
Dr. Jeff Ratliff discusses the suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide with Drs. Jonathan Watts and Robert Brown.
Dr. Gregg Day talks with Dr. Avi Nath, Clinical Director of the National Institute of Neurological Disorders and Stroke (NINDS), about COVID brain fog and other cognitive syndromes. Read the full article referenced in this podcast in the Washington Post.
Dr. Justin Abbatemarco talks with Prof. Sarosh Irani about the use of corticosteroids as a first-line agent in the treatment of LGI1 antibody encephalitis.
Dr. Jeff Burns talks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, about Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the full article discussed in this interview in the New York Times.
Dr. Karen Hirsch talks with Dr. Linnéa Grindegård about the association between EEG patterns and serum neurofilament light as a marker of neuroaxonal injury after cardiac arrest. Read the full article in Neurology.
Drs. B.J. Hicks and Andy Southerland talk with Dr. Scott Mendelson about racial and ethnic disparities in the rates of declination of thrombolysis in patients with acute ischemic stroke. Read the full article in Neurology.
Dr. Justin Abbatemarco talks with Prof. Gráinne Gorman about the use of L-arginine in the treatment of mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Read the full article in Neurology.
Dr. Fábio Nascimento talks with Dr. Elaine Pang about the identification and characterization of pure sleep epilepsy after first-ever seizures from sleep in adults. Read the full article in Neurology.
The June 2022 replay of past episodes showcases a selection of interviews about the impact of the FDA's approval of aducanumab for the treatment of Alzheimer disease (AD). This episode features illuminating conversations with Drs. Gregg Day, Ron Petersen, and Jason Karlawish on the clinical science guiding amyloid-based treatments for AD, the importance of patient participation when considering the use of aducanumab, and the business of Alzheimer disease, respectively. This month's Recall concludes with an interview featuring Pulitzer Prize-winning journalist Pam Belluck on Medicare's limitations on aducanumab coverage.
Dr. Jeff Ratliff talks with Dr. Meredith Bock about the association of motor, non-motor, and behavioral symptoms with health-related quality of life in people with Parkinson disease. Read the full article in Neurology.
In the second part of our two-part series on neurodegeneration in professional football players, Dr. Shuvro Roy talks with Dr. Ann McKee about her career and work studying the consequences of repetitive traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE).
For more information on the VA-BU-CLF Brain Bank at the Boston University CTE Center, including brain donation inquiries, click here.
Dr. Justin Abbatemarco talks with Dr. Ming Lim about the diagnosis and management of opsoclonus myoclonus ataxia syndrome (OMAS) in children. Read the full article in Neurology: Neuroimmunology & Neuroinflammation.
In the first part of our two-part series on neurodegeneration in professional football players, Dr. Shuvro Roy talks with Dr. Ann McKee about the high incidence and mortality rates of amyotrophic lateral sclerosis (ALS) in NFL athletes.
For more information on the VA-BU-CLF Brain Bank at the Boston University CTE Center, including brain donation inquiries, click here.
Dr. Derek Stitt talks with Dr. Anne Oaklander about the association of long COVID with incident polyneuropathy affecting the small-fiber axons. Read the full article in Neurology: Neuroimmunology & Neuroinflammation.
Dr. Halley Alexander talks with Dr. Shóbi Sivathamboo about the incidence of serious cardiac arrhythmias detected by subcutaneous cardiac monitors in patients with chronic drug-resistant epilepsy. Read the full article in Neurology.
Dr. Jeff Ratliff talks with Dr. Andreas Rowald about the efficacy of activity-dependent spinal cord neuromodulation, which was shown to rapidly restore trunk and leg motor functions in patients with spinal cord injury after complete paralysis.
Dr. Stacey Clardy discusses the prognostic factors and efficacy of immunosuppressive treatments for spinal cord sarcoidosis with Dr. Antoine Gavoille. Read the full article in Neurology.
Dr. Justin Abbatemarco talks with Dr. Bruce Bebo about the estimated economic burden of multiple sclerosis in the US, highlighting direct and indirect cost drivers. Read the related article in Neurology.
Please be sure to check out the National Multiple Sclerosis Society's "MS Navigator" resource, which connects patients with MS and their family members to experts who can help them navigate the challenges of MS, from making workplace accommodation requests to case management assessments.
Dr. Jeff Ratliff talks with Dr. Michael Fox about the association of connectivity between brain networks and sites of deep brain stimulation (DBS) with DBS-induced cognitive decline in patients with Parkinson disease. Check out the free clinical tool designed to help DBS programmers based on the research discussed in this episode here.
Dr. Halley Alexander talks with Dr. Mark Keezer about the risk of sudden death and cardiac arrhythmia in patients utilizing lamotrigine to treat epilepsy. Read the full article in Neurology.
Dr. Jason Crowell talks with Dr. Gregg Day about amyloid-targeting treatments for Alzheimer disease as well as how to navigate conversations about aducanumab with patients.
Dr. Tesha Monteith talks with Dr. Barbara Decker about maternal obstetric complications and non-elective postpartum readmissions in women with prior stroke, migraine, multiple sclerosis, and myasthenia gravis. Read the full article in Neurology.
Dr. Justin Abbatemarco talks with Dr. Aurora Pujol about diagnosing genetic white matter disorders by singleton whole-exome and whole-genome sequencing using interactome-driven prioritization. Read the full article in Neurology.
Dr. Tesha Monteith talks with Dr. Todd Schwedt about the treatment of chronic migraine with medication overuse through the patient-centered Medication Overuse Treatment Strategy (MOTS) clinical trial. Read the full article in Neurology.
The April 2022 replay of past episodes showcases a selection of interviews with fellow neurologists about their personal experiences as patients. This episode features illuminating conversations with Drs. Daniel Drubach, Daniel Gibbs, Ted Burns, and Oliver Sacks, offering our listeners essential lessons and insights into the importance of physician empathy.
Dr. Gordon Smith talks with Dr. Charlotte Sumner about spinal muscular atrophy, highlighting the historic milestone reached with three medications receiving FDA approval for the treatment of SMA.
Dr. Jason Crowell talks with Drs. Ariane Lewis and David Magnus about the need to update the Uniform Declaration of Death Act (UDDA), aligning the legal criteria with the medical standards used to determine death by neurological criteria. Read the full article in Neurology.
Dr. Alex Menze talks with Dr. Raquel Gardner about the development of a clinically-relevant definition of poor cognitive outcome one year after mild traumatic brain injury (mTBI) and whether outcomes can be predicted by baseline clinical variables. Read the full article in Neurology.
This episode features Dr. Stacey Clardy in conversation with the 2022 Ted Burns Humanism in Neurology Award Winner, Dr. Barbara Giesser.
Dr. Gregg Day talks with Dr. Niklas Mattsson-Carlgren about the correlation of cerebrospinal fluid biomarkers with autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration. Read the full article in Neurology.
Dr. Jeff Ratliff talks with Dr. Christos Ganos about the use of brain lesion network mapping to interrogate whether tic disorder-inducing lesions are associated with a common network in the average human brain.
Dr. Jason Crowell talks with 46brooklyn Research CEO Antonio Ciaccia about how Medicare Part D has hidden the benefits of generic competition for Tecfidera, a disease-modifying therapy for multiple sclerosis. Read the full article at 46brooklyn.com.
The March 2022 replay of past episodes showcases a selection of interviews regarding the prognosis and treatment of Guillain-Barré syndrome. This episode features Drs. Ted Burns, Jeff Ratliff, and Michelle Mauermann in conversation with Dr. Bart Jacobs over the course of a decade, highlighting the progress he and his team have made in treating and predicting outcomes in GBS over time.
Dr. Tesha Monteith talks with Dr. Elizabeth Loder about her editorial on the gender pay gap in academic neurology and its impact on women neurologists as well as the field at large. Read the full article in Neurology.
Dr. Andy Southerland talks with Dr. Daniel Chasman about the shared genetic risk of migraine, stroke, and cervical artery dissection (CeAD), a triad of neurologic disorders with vascular involvement. Read the full article in Neurology: Genetics.
Dr. Halley Alexander discusses whether epilepsy type, seizure location, or antiseizure medications influence seizure frequency during pregnancy and postpartum with Dr. P. Emanuela Voinescu. Read the full article in Neurology.
Dr. Stacey Clardy discusses the clinical, biological, and imaging features—as well as the overall clinical course—of a French cohort of patients with glial fibrillar acidic protein (GFAP) autoantibodies with Dr. Jérôme Honnorat. Read the full article in Neurology.
Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.
Dr. Jeff Ratliff talks with Dr. Bart Jacobs about his study on the validity and region-specificity of the modified Erasmus GBS Outcome Score in predicting the risk of walking inability in patients with Guillain-Barré syndrome. Read the full article in Neurology.
Dr. Stacey Clardy interviews behavioral neurologist Dr. Daniel Drubach about his experience with being diagnosed with Lewy body dementia, highlighting the unique perspective his diagnosis has provided him as a physician and as a patient. Read Dr. Drubach's special article in Continuum: "Twilight and Me: A Soliloquy."
The February 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and treatment of immune-mediated neuropathies. This episode features Drs. Stacey Clardy and Ted Burns in conversation with Drs. Luise Appeltshauser, Shahar Shelly, and P. James B. Dyck, offering listeners essential insight into the identification and management of acute autoimmune neuropathy, chronic immune sensory polyradiculopathy, and lumbrosacral radiculoplexus neuropathy.
Dr. Jason Crowell talks with Pulitzer Prize-winning New York Times journalist Pam Belluck about the impact of Medicare’s decision to limit patient access to aducanumab for the treatment of Alzheimer disease, restricting use to individuals in clinical trials.
Prof. Jon Stone talks with Dr. Tamara Pringsheim and Wall Street Journal columnist Julie Jargon about the increased incidence of teen girls presenting with physical tics and the potential association of exposure to TikTok videos on Tourette syndrome and functional neurologic disorder (FND).
Dr. Jeff Ratliff talks with Dr. Winston Chiong about the new AAN Position Statement on ethical considerations in the use of aducanumab for patients with Alzheimer disease.
Dr. Dan Ackerman talks with Dr. Gaspard Gerschenfeld about the efficacy, safety, and outcomes of treating large vessel occlusion stroke with tenecteplase before thrombectomy.
Dr. Halley Alexander discusses the utility of a new systematic classification of epilepsy-related mortality used in a nationwide cohort study of children and young adults in Denmark with Dr. Marius Kløvgaard.
Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.
Dr. Halley Alexander talks with Dr. Ezequiel Gleichgerrcht about the association between the anatomical location of surgical lesions and postoperative seizure outcomes in patients with temporal lobe epilepsy.
Dr. Halley Alexander discusses the AAN Guideline Subcommittee’s practice advisory update on antiseizure medication withdrawal in seizure-free patients with Dr. Alison Pack.
Dr. Jeff Ratliff talks with Dr. Michael Alosco about the association between antemortem FLAIR white matter hyperintensities and neuropathology in brain donors exposed to repetitive head impacts.
The January 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and effects of traumatic encephalopathy syndrome (TES) and concussions. This episode features Dr. Alex Menze in conversation with Dr. Robert Stern, Dr. Nathan Churchill, and Prof. Antonio Belli, offering listeners a comprehensive understanding of the diagnosis and management of head trauma.
Celebrate the 70th Anniversary of Neurology® with Part II of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.
Celebrate the 70th Anniversary of Neurology® with Part I of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.
In the first part of the podcast, Dr. Halley Alexander discusses the effectiveness of the three first line treatments for infantile spasms with Dr. Zachary Grinspan (00:51). In the second segment, Dr. Gordon Smith talks with Dr. Ricardo Taipa about the clinical manifestations, imaging results, and neuropathological findings associated with CNS involvement in hereditary transthyretin amyloidosis (14:53).
In the first part of the podcast, Dr. Justin Abbatemarco talks with Dr. Avi Nath, Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, about COVID-19 vaccines and neurology immunotherapy (00:56). In the second segment, Dr. Andy Southerland discusses disparities in the utilization of stroke interventions with Dr. Adam de Havenon (18:18).
The December 2021 replay of past episodes showcases a selection of interviews regarding the diagnosis and management of stroke. This episode features Dr. Andy Southerland and Will Rondeau in conversation with Drs. Seemant Chaturvedi, Lee Schwamm, Jyri Virta, and Sidsel Hastrup, offering listeners a review across the field of vascular neurology.
In the first part of the podcast, Dr. Stacey Clardy talks with Dr. Christopher Klein about small fiber neuropathy incidence, prevalence, longitudinal impairments, and disabilities (00:45). In the second segment, Dr. Amy Guzik discusses the representation of women in stroke clinical trials relative to the burden of disease in the population with Dr. Cheryl Carcel (16:12).
In the first part of the podcast, Dr. Tesha Monteith discusses the International Headache Society and European Headache Federation 2021 joint International Headache Congress with Dr. Patricia Pozo-Rosich (00:45). In the second segment, Dr. Jeff Ratliff talks with Dr. Jan Rusz about identifying speech subtypes in patients with Parkinson disease in response to long-term dopaminergic therapy (8:18).
In the first part of the podcast, Dr. Jason Crowell discusses the AAN Guideline Subcommittee's practice guideline summary on dopaminergic therapy for motor symptoms in early Parkinson disease with Dr. Anthony Lang (00:45). In the second segment, Dr. Kathryn Nevel talks with Dr. Amanda Guidon about the development of consensus disease definitions for neurologic immune-related adverse events associated with immune checkpoint inhibitors (17:04).
In the first part of the podcast, Dr. Stacey Clardy discusses the causes, features, evaluation, and treatment of chronic meningeal inflammation or infection with Dr. Allen Aksamit. In the second segment, Dr. Eoin Flanagan talks with Dr. Tomas Kalincik about the associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis (26:48).
In the first part of the podcast, Dr. Gregg Day discusses the importance of patient participation in the decision-making process when considering the use of aducanumab for the treatment of Alzheimer disease with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer’s Disease Center. In the second segment, Dr. Andy Southerland talks with Dr. Jyri Virta about the risk of aneurysm rupture after thrombolysis in patients with acute ischemic stroke and unruptured intracranial aneurysms.
In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.
In the first part of the podcast, Dr. Jason Crowell talks with Dr. Kiran Thakur about the importance of monitoring COVID-19 vaccines for neurologic adverse events and learning from past vaccination programs. In the second segment, Dr. Jeff Ratliff interviews Dr. Carles Gaig about the frequency and types of movement disorders in patients with anti-IgLON5 disease.
In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.
In the first part of the podcast, Dr. Ted Burns interviews legendary musician Peter Frampton about his experience with inclusion body myositis and his storied career. For more with Peter Frampton, read the cover story in the October/November 2020 issue of Brain & Life, the AAN’s patient and caregiver magazine. In the second segment, Dr. Gordon Smith talks with Dr. Amy Tsou about the updated AAN Position Statement on ethical concerns raised by high drug costs.
The October 2021 replay of past episodes showcases a selection of interviews focused on thunderclap headache. This episode features Dr. Tesha Monteith in conversation with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, as well as with headache experts Drs. Jonathan Smith, Dileep Yavagal, and Alexandra Cocores.
In the first part of the podcast, Dr. Jeff Ratliff talks with Dr. Winston Chiong about the updated AAN Position Statement on Ethical Considerations in Dementia Diagnosis and Care. In the second segment, Dr. Gregg Day talks with Dr. Emily Edmonds about differing cognitive, biomarker, and neuropathologic trajectories in subtypes of mild cognitive impairment.
Dr. Alex Menze discusses the acute and chronic effects of a history of concussions with Dr. Nathan Churchill.
In the first part of the podcast, Dr. Stacey Clardy talks with Dr. Eoin Flanagan about how MRI T-2 lesion evolution differs across central nervous system demyelinating disorders. In the second segment, Dr. Teshamae Monteith talks with Dr. Gabriela Carvalho about behavioral and neuronal responses to a virtual roller coaster ride in patients with migraine.
In the first part of the podcast, Dr. Andy Southerland talks with Dr. Edward Chang about the use of a neuroprosthesis for decoding speech in a paralyzed person with anarthria. In the second segment, Dr. Jeff Ratliff discusses the trajectory and magnitude of the progression of clinical features in Lewy body dementia with Dr. Elie Matar.
The September 2021 replay of past episodes showcases a selection of interviews focused on the management of myasthenia gravis. The selected interviews feature Dr. Ted Burns and Dr. Stacey Clardy in conversation with Drs. Gil Wolfe, Joseph Shrager, and Pushpa Narayanaswami before closing with before closing with notes from Dr. Ted Burns on MuSK myasthenia gravis.
In the first segment, Dr. Matthew Barrett talks with Dr. Simone Baiardi about using real-time quaking-induced conversion (RT-QuIC) to identify patients with Lewy body disease. In the second part of the podcast, Dr. Jeff Ratliff discusses the association of central hypersomnia and fatigue in multiple sclerosis with Dr. Anne-Laure Dubessy.
In the first segment, Dr. Stacey Clardy talks with Dr. Daniel Hartung about whether closing the Part D coverage gap between 2010-2019 lowered patients’ out-of-pocket costs for multiple sclerosis drugs. In the second part of the podcast, Dr. Teshamae Monteith discusses sex, exercise, and other benign causes of thunderclap headache with Dr. Jonathan Smith in the final part of our four-part series on thunderclap headache.
In the first segment, Dr. Jason Crowell talks with Dr. Paul Ford about patient perceptions of the FDA approval process for disease modifying therapies in people living with multiple sclerosis. In the second part of the podcast, Dr. Teshamae Monteith discusses the management of cerebral aneurysm with Dr. Dileep Yavagal in the third part of our four-part series on thunderclap headache.
In the first segment, Dr. Halley Alexander talks with Dr. Pia De Stefano about the safety and efficacy of artificial coma induction in the treatment of status epilepticus. In the second part of the podcast, Dr. Teshamae Monteith discusses a case presentation of RCVS and clinical management with Dr. Andy Southerland and his patient, Martien Halvorson-Taylor, in the second part of our four-part series on thunderclap headache.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
In the first segment, Dr. Jon Stone talks with Dr. Anne Sofie Hansen about the spectrum and risk of psychiatric disorders in childhood-onset psychogenic nonepileptic seizures. In the second part of the podcast, Dr. Teshamae Monteith discusses ten causes of thunderclap headache and presentation with Dr. Alexandra Cocores in the first part of our four-part series on thunderclap headache.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology® Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online podcast quiz.
This month’s replay of past episodes showcases a selection of interviews concerning the FDA approval of aducanumab for the treatment of Alzheimer disease from clinical, political, and economic perspectives. The selected interviews feature conversations between Dr. Gregg Day and Pam Belluck, Dr. Jeff Burns and Dr. Ron Peterson, Dr. Jason Crowell and Dr. Steve Pearson, and Dr. Jeff Burns and Dr. Daniel Gibbs.
Dr. Stacey Clardy discusses the impact of surgical approaches to thymectomy upon remission rates in myasthenia gravis with Dr. Joseph Shrager.
In the first segment, Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein. In the second part of the podcast, Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.
In the first segment, Dr. Alex Menze talks with Dr. Clifford Saper about Havana Syndrome and recent attacks on American diplomats. In the second part of the podcast, Dr. Jeff Ratliff discusses the natural history of afferent baroreflex failure with Dr. Guillaume Lamotte.
In the first segment, Dr. Gregg Day speaks with Dr. Josep Dalmau about NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis. In the second part of the podcast, Dr. Jeff Burns talks to neurologist Dr. Daniel Gibbs about his Alzheimer’s disease diagnosis and experience participating in a clinical trial for aducanumab.
This month's replay of past episodes showcases a selection of interviews on the impact of pregnancy on various neurologic disorders, featuring Drs. Page Pennell, Paula Emanuela Voinescu, Mary Angela O'Neal, Emma Ciafaloni, Raed Alroughani, Rae Bacharach, Annette Langer-Gould, Nicolas Collongues, and Petra Ijäs.
This second installment in our two-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.
Dr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.
This first installment of a 2-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.
Dr. Jeff Burns, Director of the University of Kansas Alzheimer’s Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
The first segment features Dr. Stacey Clardy in conversation with 2021 Ted Burns Humanism in Neurology Award recipient Dr. John Quinlan. In the second part of the podcast, Dr. Andy Southerland discusses the risk of readmission following inpatient admission for reversible cerebral vasoconstriction syndrome with Dr. Santiago Ortega-Gutierrez.
In the first segment, Dr. Jeff Ratliff discusses primary care management for acute sciatica and physical therapy referrals with Dr. Julie Fritz. In the second part of the podcast, Dr. Andy Southerland talks with Dr. Amrou Sarraj about efficacy and safety of direct endovascular thrombectomy compared to bridging therapy in patients with large vessel occlusions.
This month's replay of past episodes showcases a selection of interviews by Drs. Jeff Burns, Jason Crowell, and Gregg Day on updates in Alzheimer's disease diagnostics and the impact of future therapies, featuring Drs. Michael Weiner, Randall Bateman, Erik Musiek, Joseph Therriault, and Yvette Sheline.
Dr. Alex Menze speaks with Prof. Antonio Belli about the role of salivary small non-coding RNAs in the diagnosis of sport-related concussion.
Dr. Stacey Clardy speaks with Dr. Petra Ijäs about the incidence of stroke during pregnancy or puerperium in Finland from 1987-2016.
In the first segment, Dr. Jason Crowell discusses a natural history study of “pure” primary lateral sclerosis with Dr. Anhar Hassan. In the second part of the podcast, Dr. Andy Southerland talks with Dr. Roland Faigle about the assessment of critical care needs for patients with spontaneous intracerebral hemorrhage.
In the first segment, Dr. Andy Southerland talks with Dr. Mijail Serruya about developing a brain-machine interface for patients with stroke. In the second part of the podcast, Dr. Jason Crowell discusses the relationship between CAG repeat length and cognition in adult patients with Dr. Jordan Schultz.
In the first segment, Dr. Alex Menze talks to Dr. Robert Stern about developing NINDS consensus diagnostic criteria for traumatic encephalopathy syndrome. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Adam de Havenon about five-year cost trends and utilization of neurologist-prescribed drugs for Medicare Part D beneficiaries.
This month's replay of past episodes features a selection of Neurology Minute segments in which Dr. Chris Boes discusses the history of neurology and the neurologic exam.
Dr. Jeff Burns speaks with Prof. Maria Eriksdotter about whether cholinesterase inhibitors are associated with slower cognitive decline and decreased mortality risk.
Dr. Derek Stitt speaks with FDA Center for Biologics Evaluation and Research Director Dr. Peter Marks about cases of thrombosis after the Johnson & Johnson COVID-19 vaccine, potential risk factors, and suggestions for patient care.
Dr. Ted Burns talks with Drs. P. James B. Dyck and Shahar Shelly about clinical, neurophysiological, and pathological features of CISP-plus in comparison to CISP.
Dr. Jason Crowell discusses racial and ethnic health disparities exacerbated by COVID-19 with Drs. Leo Lopez III and Louis Hart.
In the first segment, Dr. Stacey Clardy talks to Jade Smith about financial conflicts of interest of authors published in high-impact neurology journals. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Emily Largent about potential advancements and ethical challenges associated with blood testing for Alzheimer disease.
This month's replay of past episodes features four segments in which Dr. Fábio Nascimento discusses the diagnosis and management of epilepsy with Drs. Elizabeth Thiele, Helen Cross, Orrin Devinsky, and Atul Maheshwari. For discussion questions for your next journal club talk, go here.
In the first segment, Dr. Halley Alexander speaks with Dr. Page Pennell about seizure frequency and treatment during pregnancy. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Elizabeth Emma Palmer about genetic testing in epileptic encephalopathy. Access resources for clinicians and families with information on when to consider genetic testing for epilepsy, what tests are available, and what their advantages or limitations may be.
Dr. Stacey Clardy talks with Dr. Anthony Amato about bimagrumab in sporadic inclusion body myositis.
In the first segment, Dr. Teshamae Monteith talks with Dr. Paul Mathew on the prevalence of occipital neuralgia at a community hospital-based headache clinic. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Drs. Lola Cook and Roy Alcalay about genetic testing for Parkinson disease.
Dr. Jeff Ratliff talks with Dr. Wilson Abdo about prolonged unconsciousness in COVID-19.
In the first segment, Dr. Jason Crowell talks to Dr. Erik Musiek about disease-modifying therapy in Alzheimer disease. In the second part of the podcast, Dr. Andrew Southerland talks with Dr. Fana Alemseged about tenecteplase versus alteplase in basilar artery occlusion.
This month's Neurology Recall features Dr. Jason Crowell discussing prion diseases with both Dr. Sonia Vallabh and Nobel Prize Winner Dr. Stanley Prusiner.
In the first segment, Will Rondeau speaks with Dr. Sidsel Hastrup about inpatient vs outpatient management of TIA and stroke. In the second part of the podcast, Dr. Fabio Nascimento talks with Dr. Atul Maheshwari in the final part of our four-part series called Update in Epilepsy.
In the first segment, Dr. Gregg Day talks with Dr. Joseph Therriault on the frequency of biologically defined Alzheimer’s. In the second part of the podcast, Dr. Fabio Nascimento talks with Dr. Orrin Devinsky in the third part of a four-part series called Update in Epilepsy.
In the first segment, Dr. Jason Crowell talks with Dr. Jeffrey Rumbaugh about the latest Lyme Disease Guidelines. In the second part of the podcast, Dr. Fabio Nascimento talks with Dr. Helen Cross in the second part of a four-part series called Update in Epilepsy.
This month's replay of past episodes features clinical pearls, diagnosis, and treatment of migraine with Dr. Teshamae Monteith. For discussion questions for your next journal club talk, go here.
In the first segment, Dr. Halley Alexander talks to Dr. Nishant Sinha about predicting seizure recurrence via brain networks. In the second part of the podcast, Dr. Fabio Nascimento talks with Dr. Elizabeth Thiele in the first part of a four-part series called Update in Epilepsy.
In the first segment, Dr. Jason Crowell speaks with Dr. Jennifer Frontera about neurology and COVID-19 in New York City. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Dr. Abhimanyu Mahajan and Dr. Erica Schuyler about immigrant neurologists in the United States.
Dr. Stacey Clardy receives an update from Dr. Pushpa Narayanaswami on the management of myasthenia gravis.
Dr. Stacey Clardy talks with Dr. Chloe Hill about increasing out-of-pocket costs for privately-insured patients to obtain neurologic diagnostic services.
In the first segment, Will Rondeau talks with Dr. Lee Schwamm about the latest on cryptogenic stroke. In the second part of the podcast, you’ll hear Dr. Stacey Clardy’s interview with Dr. Zsolt Laszlo Illés about the worldwide impact of neuromyelitis optica.
In the first segment, Dr. Stacey Clardy talks to National Academy of Medicine inductee Dr. Merit Cudkowicz about her research and work. In the second part of the podcast, Dr. Clardy talks with Dr. Katharina Fink about antibody therapy for pregnant women with multiple sclerosis.
Podcast founding editor Dr. Ted Burns introduces our Neurology Recall on Parkinson disease (PD), which features short segments discussing non-motor clinical manifestations, treatment options for motor manifestations, and recent advances in PD. This is a compilation of contributions to the Neurology Minute™ from the past 22 months since its launch in February 2019.
Dr. Avi Nath discusses updates on the vaccines, how things are going in schools, and what we might expect in 2021.
Dr. Avi Nath discusses updates on the vaccines, how things are going in schools, and what we might expect in 2021.
Drs. Monteith and Silberstein discuss all the new medications, and how and when to use them.
In the first segment, Dr. Teshamae Monteith talks with Dr. Janis Miyasaki about gender representation in AAN leadership, publication, and awards. In the second part of the podcast, Dr. Jason Crowell speaks with journalist Jamie Talan about posterior cortical atrophy.
This month's replay of past episodes features talks to help with the basics of treatment and prevention of stroke. This month highlights 3 segments featuring Dr. Dan Ackerman talking with Dr. Andrew Southerland, in a comprehensive talk on the care of stroke patients. Here are some questions and topics you might want to discuss at your journal club after you have listened to the November 2020 (1 &2) and December (3, 4 & 5) 2020 Neurology Recall on Stroke Management.
In the first segment, Dr. Stacey Clardy talks with Dr. Roy Freeman about his paper discussing idiopathic distal sensory polyneuropathy. In the second part of the podcast, Dr. Clardy talks with Dr. Justin McArthur about his research, work, and the National Academy of Medicine Award.
Dr. Jason Crowell talks with Dr. Jennifer Shum about her paper on neural correlates of sign language production.
In the first segment, Dr. Jason Crowell speaks with Dr. Martha Barnette of the 'A Way with Words' podcast about language, words, and neurology. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Dr. Bonnie Scott about her paper on apathy and impulse control disorders in Parkinson disease.
Dr. Ima Ebong and Dr. Eseosa Ighodaro discuss the changes in neurology education surrounding racial disparities.
https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=1012
In the first segment, Dr. Jeff Burns talks with Dr. Yvette Sheline about her paper on the Effect of escitalopram on CSF Aβ. In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Elizabeth Finger about her article on the neural effects of oxytocin on frontotemporal dementia, also from this week’s issue.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
Dr. Derek Bauer talks with Dr. Christoph Beier about his paper on predicting treatment response in generalized epilepsy.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
This month's replay of past episodes features talks to help with the basics of treatment and prevention of stroke. This month highlights 2 segments featuring Dr. Dan Ackerman talking with Dr. Andrew Southerland, in a comprehensive talk on the care of stroke patients.
Dr. Jeff Burns speaks with Dr. Michael Weiner about his New York Times article on blood tests for Alzheimer’s disease. Read the article here: https://nyti.ms/3cKheMW.
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Elizabeth Matthews about her paper on super-refractory status epilepticus. In the second part of the podcast, Dr. Jason Crowell speaks with Matthew Futterman about hit New York Times article on neurologic sequela in sledding athletes. Read the NYT article here: https://nyti.ms/3mNBlhE.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
Matthew Futterman, a sportswriter for The New York Times, discusses his article, Sledhead - Sledding Athletes Are Taking Their Lives. Did Brain-Rattling Rides and High-Speed Crashes Damage Their Brains?
Show references:
https://www.nytimes.com/2020/07/26/sports/olympics/olympics-bobsled-suicide-brain-injuries.html
In honor of the recent Nobel Prize award for chemistry awarded to Emmanuelle Charpentier and Jennifer Doudna for their discovery of the CRISPR/Cas9 genetic scissors. This episode highlights past coverage of CRISPR, starting with Dr. Ted Burns talking with Eric Olson, from the 2016 Annual Meeting. Dr. Jason Crowell focuses his discussion with Dr. Heidi Ledford on CRISPR babies and what's needed to make gene editing safe, from August 2019. From May 6th, 2019, Dr. Jason Crowell speaks with Pam Belluck of the NYT on gene editing and CRISPR. Finally, we highlight a December 2018 episode where Dr. Jason Crowell talks with Dr. Josephine Johnston of the Hastings Center on the ethical and philosophical implications of gene editing.
In the first segment, Dr. Jeffrey Ratliff speaks with Dr. A.M. Madelein van der Stouwe about her Journal of Neurology, Neurosurgery, and Psychiatry article on diagnosing arm tremor. Read the article here: https://bit.ly/3iETrQD. In the second part of the podcast, Dr. Andrew Southerland talks with Dr. Michael Knoflach and Dr. Lukas Mayer about their paper discussing extracellular matrix protein in cervical artery dissection.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
Dr. Jason Crowell continues his discussion with Dr. Sonia Vallabh on a profile of prion disease, in the second part of a 2-part interview.
In this month's replay of past episodes, we cover movement disorder emergencies, featuring discussion between podcast editors Dr. Jeffrey Ratliff and Dr. Jason Crowell, from July 13th and 20th. For discussion questions for your next journal club talk, go here.
In the first part of the podcast, Dr. Jason Crowell speaks with Dr. Sonia Vallabh about her life and work in prion disease, in the 1st part of a 2-part series. Dr. Vallabh has been profiled in WIRED and the New York Times. Next, Dr. Teshamae Monteith talks with Dr. Joanne Fielding about her paper discussing visual processing in visual snow syndrome.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
In the first segment, Dr. Jason Crowell talks with Eric Pachman about his report on copaxone and drug pricing. Next, Dr. Jeffrey Ratliff talks with Dr. Yi Li about her Neurology: Clinical Practice paper discussing ultrasound-guided lumbar puncture.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
Dr. Teshamae Monteith talks with Dr. Ralph Sacco about health disparities and inequities in light of COVID-19.
In the first segment, Dr. Dan Ackerman and Dr. Andrew Southerland finish their discussion on managing ischemic stroke, in the 5th of a 5-part series. Next up, Dr. Stacey Clardy talks with Dr. Luise Appeltshauser about her paper discussing paranodal antibodies in acute autoimmune neuropathy. Read Dr. Appelshauser's paper in Neurology: Neuroimmunology & Neuroinflammation: https://nn.neurology.org/content/7/5/e817.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
Dr. Dan Ackerman and Dr. Andrew Southerland continue their discussion on managing ischemic stroke, in the 4th of a 5-part series. Dr. Jason Crowell talks with Dr. Lara Jehi about her paper discussing surgery costs in temporal lobe epilepsy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
In this month's replay of past episodes, we cover treatment and management of status epilepticus, featuring discussion between Dr. Halley Alexander and Dr. Michael Sperling. For discussion questions for your next journal club talk, go here.
Dr. Dan Ackerman and Dr. Andrew Southerland continue their discussion on managing ischemic stroke, in the 3rd of a 5-part series. In the second segment, Dr. Halley Alexander talks with Dr. Martha Morrell about her paper discussing neurostimulation in focal epilepsy.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
In the 2nd of a 5-part series on managing ischemic stroke, Dr. Andrew Southerland talks with Dr. Dan Ackerman. Dr. Gregg Day talks with Dr. Brian Appleby about his paper discussing diagnostic testing for prion disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the 1st of a 5-part series on managing ischemic stroke, Dr. Andrew Southerland talks with Dr. Dan Ackerman. Dr. Stacey Clardy talks with Dr. Elizabeth Coon about her paper discussing phenoconversion in pure autonomic failure.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.
Dr. Stacey Clardy talks with Dr. Avindra Nath on an update on COVID-19, what we know, update on vaccines, and where we go from here.
Dr. Jeffrey Ratliff talks with Dr. Nico Dosenbach about plasticity of functionally connected motor networks. Read Dr. Dosenbach's paper in Neuron: https://www.sciencedirect.com/science/article/abs/pii/S0896627320303536?via%3Dihub.
In this replay of previous episodes, we feature discussions on Huntington's disease. There's the discussion between Dr. Jeffrey Ratliff and Dr. Ruth Walker from November 2016. Then, we have 2 Neurology Minute episodes on the history of HD. The next segment features Dr. Jason Crowell talking with Dr. Nancy Wexler from May 2020, on her life's work in HD research and on her life. From July 2019, Dr. Jeffrey Ratliff talks with Dr. Sarah Tabrizi on targeting HD expression in patients. Finally, in July 2020, Dr. Jason
In the first segment, Dr. Andrew Southerland speaks with Dr. J.G. Makin about his Nature article on thought-to-text technology. Then, Dr. Jason Crowell talks with Dr. Jonathan Kimmelman about his paper on expert crowd prediction on clinical trial response. Dr. Makin's article is available online at: https://www.nature.com/articles/s41593-020-0608-8.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Kathryn Nevel and Dr. Jennie Taylor discuss neuro-oncology. Next, Dr. Jeffrey Ratliff talks with Dr. David Charles about his paper discussing deep brain stimulation in early Parkinson disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first part of the podcast, Dr. Jeffrey Ratliff and Dr. Jason Crowell continue their discussion on movement disorder emergencies in the 2nd part of a 2-part dialogue. In the second segment, Dr. Stacey Clardy talks with Dr. Holly Hinson about her Neurology: Clinical Practice editorial on patient and public involvement in clinical trials from the June 2020 issue.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
Dr. Stacey Clardy talks with Dr. Steven L. Lewis about maintaining vibrant practice, planning for the future in light of COVID-19, and addressing long-term concerns.
In the first segment, you’ll hear the first part of a 2-part conversation between Dr. Jeffrey Ratliff and Dr. Jason Crowell on movement disorder emergencies. In the second segment, Dr. Stacey Clardy talks with Dr. John Chen about his Neurology paper discussing maintenance therapy for MOG-IgG disorder.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Jason Crowell talks with Dr. Daniel Claassen about his Neurology: Genetics paper on genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. In the second part of the podcast, Dr. Jeffrey Ratliff focuses his discussion with Dr. Roseanne Dobkin on telephone-based CBT for depression in patients with Parkinson disease.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
Dr. Luca Bartolini leads a roundtable discussion on diagnosis and management of post-concussive headache with experts Dr. Teshamae Monteith and Dr. Marc DiSabella based on a Practice Current survey run between March and November 2019.
In the 2nd part of this 2-part series, Dr. Halley Alexander interviews Dr. Michael Sperling about management of status epilepticus.
In the 1st part of this 2-part series, Dr. Halley Alexander interviews Dr. Michael Sperling about management of status epilepticus.
In this replay of previous episodes, Dr. Ted Burns talks with John D. Stewart on the common mononeuropathies: median, ulnar, radial, and paroneal.
Dr. Jeffrey Ratliff talks with Dr. Jeffrey Schweitzer about his NEJM paper discussing progenitor cells for Parkinson disease. Read the NEJM article here: https://bit.ly/2XjHvuc.
You'll hear the second part of an interview on migraine between Dr. Jason Crowell and Dr. David Watson, focusing on special patient populations in management of migraine.
In the first segment, Dr. Jason Crowell talks with Dr. David Watson about managing migraine in the first part of a two-part series. In the second segment, Dr. Jeff Ratliff talks with Dr. Jason Jonathan Sico about his Neurology paper on improving quality outcomes measurement sets. Part of the information in the discussion with Dr. Watson can be found in this paper in Current Pain and Headache Reports: https://link.springer.com/article/10.1007/s11916-019-0749-1.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In this replay of previous episodes, we features discussions on the treatment of neuromyelitis optica. We begin with Dr. Ted Burns' interview of Dr. Stacey Clardy from Dec. 2019 on treatment and prevention of disease activity. From October 2019, Dr. Stacey Clardy talks with Dr. Sean Pittock on eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder. The 3rd segment is from Nov. 2019 and features Dr. Clardy's talk with Dr. Silvia Tenembaum about prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination. Next, there's Stacey Clardy's talk with Dr. Richard Burt on autologous, nonmyeloablative hematopoietic stem-cell transplantation for neuromyelitis optica. Finally, Dr. Jeff Ratliff talks with Dr. Maureen Mealy, from May 2020, about scrambler therapy for NMO-related pain.
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Yves Dauvilliers about their paper on insomnia treatment in the elderly. In the second part of the podcast, Dr. Jason Crowell continues his talk with Dr. Nancy Wexler about living with Huntington's disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, you'll hear the first part of an interview between Dr. Jason Crowell and Dr. Nancy Wexler on living with Huntington's disease. In the second segment, Dr. Andrew Southerland talks with Dr. Steven Messe on his practice advisory update summary paper on patent foramen ovale and secondary stroke prevention.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In this replay of past episodes, we focus on interviews about the connectome. In the first interview, from Feb. 2019, Dr. Stacey Clardy talks with Dr. Michael Fox on mapping symptoms to brain networks. From Aug. 2019, Dr. Jeff Ratliff talks again with Dr. Michael Fox about network localization of cervical dystonia based on causal brain lesions. In the final interview, Dr. Nico Dosenbach talks about neural networks as they relate to deep brain stimulation, from a talk with Dr. Jeff Ratliff from April 2020.
Dr. Teshamae Monteith talks with Dr. Scott Hirsch about treatment of adult ADHD.
Dr. Jason Crowell talks with Dr. Renee Shellhaas on courage during COVID-19 and on demonstrating leadership as neurologists in these circumstances. Read Dr. Shellhaas' special editorial: https://n.neurology.org/content/early/2020/04/24/WNL.0000000000009496. For a clearing house of neurology related information on the coronavirus go to https://www.aan.com/tools-and-resources/covid-19-neurology-resource-center/ to stay up-to-date.
In the first segment, Dr. Jeff Ratliff speaks with Dr. Scott Mintzer about epilepsy in the elderly. In the second segment, Dr. Jeff Ratliff talks with Dr. Maureen Mealy about her paper on the use of scrambler therapy for pain in neuromyelitis optica.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In this replay of past episodes of Delayed Recall, we have the April 2015 interviews focusing on systemic causes of myelopathies and, then, interviews from 2018 on acquired myelopathies.
In the first segment, Dr. Greg Day speaks with Dr. Sharon Inouye about her NEJM article providing an update on delirium. The article is available online at: https://bit.ly/2UCh2Xo. In the second segment, Dr. Dan Ackerman talks with Dr. Adam Brickman about his Neurology paper on nocturnal blood pressure and cognition.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
Dr. Jason Crowell talks with Dr. Neil Busis and Dr. Brad Klein about teleneurology, tips for billing, and exams during the COVID-19 pandemic. Read the special editorial by Drs. Busis and Klein: https://n.neurology.org/content/early/2020/04/24/WNL.0000000000009494. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
Dr. Stacey Clardy talks with Dr. Ken Tyler about misinformation about SARS-CoV2 & gives updates on antibody testing and ongoing clinical trials. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
In the first segment, Dr. Rae Bacharach talks with Dr. Karen Hirsch about her paper on the prognostic value of diffusion-weighted MRI for post-cardiac arrest coma. In the second part of the podcast, Dr. Teshamae Monteith speaks with Dr. Richard Lipton about his Neurology® paper on eptinezumab for migraine, from the March 31st issue.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
Dr. Jeff Ratliff talks with Dr. Anna Bersano about being a neurologist in Italy during the COVID-19 pandemic. Read Dr. Bersano's special editorial in Neurology: https://n.neurology.org/content/early/2020/04/01/WNL.0000000000009508. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
In this replay of a past Delayed Recall, Dr. Ted Burns talks with Dr. Dean Buonomano, author of Brain Bugs, on how the brain makes and forgets memories.
In the first segment, Dr. Jason Crowell speaks with Dr. Andrew Southerland about Neurology on the Hill. In the second part of the podcast, Dr. Matthew Harms talks with Dr. Steve Vucic about his paper on multiple hit theory of ALS.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
Dr. Teshamae Monteith talks with Dr. Joseph Kvedar about value-based care, e-consults, and telemedicine. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
Dr. Teshamae Monteith talks with Dr. Melissa Ko about telemedicine for neurologists caring for patients in light of COVID-19. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
In the first segment, Dr. Jeff Ratliff talks with Dr. Nico Dosenbach about his Neuron paper on neural networks and deep brain stimulation, and they specifically cover the Neurology Today article on this paper with respect to the impact on DBS. In the second part of the podcast, Dr. Jeff Ratliff speaks with Dr. Alberto Espay about his paper—from the March 17th issue of Neurology—on reconsidering biomarkers in Parkinson disease. You can read the Neurology Today story here: https://bit.ly/2TzJr0Y; and you can read the Neuron paper here: https://bit.ly/2TX1zku.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
Dr. Ian Lipkin discusses his own diagnosis with COVID-19 and what neurologists can do in light of the pandemic to keep safe and to serve patients. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
Find the cast of Contagion's PSAs on the pandemic: https://abcnews.go.com/Entertainment/cast-contagion-issues-psa-coronavirus-pandemic/story?id=69853838.
Find Columbia University's Control the Contagion page: https://www.publichealth.columbia.edu/controlthecontagion.
In the first segment, Dr. Jason Crowell talks with Dr. Daniel Hartung about his paper on the effect of generic glatiramer acetate on the reduction of MS costs. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Brian Callaghan about his paper—also from the March 31st issue of Neurology—on the association between out-of-pocket costs and adherence to common neurologic medications.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
Dr. Avindra Nath provides a special report on what clinicians need to know about neurologic symptoms and complications of COVID-19.
For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
In the first segment, Dr. Matthew Barrett talks with Dr. John-Paul Taylor about his paper on Lewy body dementia management, from The Lancet. In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Chris Butler about his paper on pathologic tearfulness after limbic encephalitis. You can read Dr. Taylor’s paper in The Lancet here: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30153-X/fulltext.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
Dr. Jason Crowell speaks with Dr. John Noseworthy on his NEJM article on preserving the physician-patient relationship, which you can read here: https://www.nejm.org/doi/full/10.1056/NEJMsr1912662.
Dr. Halley Alexander talks with Dr. Emma Foster about her Neurology paper discussing that antiepileptic drugs are not independently associated with cognitive dysfunction.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
Dr. Jason Crowell speaks with Denise Roland of the Wall Street Journal about her story on an obscure model driving down drug costs. You can read their paper in the Wall Street Journal here: https://www.wsj.com/articles/obscure-model-puts-a-price-on-good-healthand-drives-down-drug-costs-11572885123.
This month’s Delayed Recall highlights 6 interviews on encephalopathies from the March and April 2013 Delayed Recall episodes. You’ll hear about encephalopathies caused by endocrine disorders, by electrolyte disorders, by liver and kidney failure, and by other organ failure. The other interviews cover encephalopathies caused by systemic disease, such as encephalopathies caused by drugs or miscellaneous causes, including vitamin deficiencies and autoimmune disorders.
Dr. Stacey Clardy talks with Dr. Robert Silbergleit and Dr. Jaideep Kapur about anticonvulsant medications for status epilepticus. You can read Dr. Silbergleit and Dr. Kapur's paper in the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMoa1905795.
Dr. Stacey Clardy talks with Dr. Ken Tyler about infectious encephalitis and arthropod-borne infections in 2019.
In the first interview, Dr. Teshamae Monteith talks with Dr. Francesca Puledda about her paper on clinical and phenotypical descriptions of visual snow syndrome patients. In the second interview, Dr. Jason Crowell talks with Ed Silverman about the settlement over allegations a patient charity helped drug makers pay kickbacks to Medicare patients over MS drugs. You can read the STAT article here: https://www.statnews.com/2019/11/20/patient-charity-allegations-ms-drug-makers-kickbacks/.
In the first segment, Dr. Jason Crowell talks with Dr. Timothy Yu about patient-customized oligonucleotide therapy for a rare genetic disease. In the second part of the podcast, Dr. Jeffrey Burns talks with Dr. Amy Sanders about her implementation update on quality improvement in dementia care. You can read Dr. Yu’s paper in the NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa1813279.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
This month’s Delayed Recall highlights episodes on CTE and head trauma. Dr. Jason Crowell talks with Dr. Jesse Mez on his work on chronic traumatic encephalopathy and American football players, from the August 29, 2017. The next segment, from January 21, 2020, features Dr. Jeff Ratliff interviewing Dr. Charles Bernick on MRI biomarkers in boxers and MMA fighters. Next, from April 3, 2018, Dr. Lee Goldstein discusses teen concussion and early tauopathy with Dr. Jeff Ratliff. Finally, we feature the November 6, 2012 interview between Dr. Jeff Kutcher and Dr. Everett Lehman about his paper on NFL players and neurologic causes of death.
Dr. Jason Crowell talks with Dr. Daniel Hartung about his qualitative study on drug prices for MS.
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Charles Bernick about his paper on longitudinal change in regional brain volumes with exposure to repetitive head impacts. In the second part of the podcast, Dr. Teshamae Monteith talks with Dr. Amy Gelfand about infant colic and episodic syndromes.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Stacey Clardy talks with Dr. Francesc Graus and Dr. Josep Dalmau about their paper on Hashimoto encephalopathy in the 21st century. In the second part of the podcast, Dr. Teshamae Monteith talks with Dr. Richard Lipton and Dr. Dawn Buse about migraine progression in subgroups of migraine based on comorbidities.
Dr. Michelle Mauermann talks with Dr. Mary Reilly about her paper on targeted, next-generation, sequencing panels in the diagnosis of Charcot-Marie-Tooth disease.
This month’s Delayed Recall highlights episodes from Nobel Prize winners. Dr. Jason Crowell talks with Dr. Stanley Prusiner on his work, from the October 15th and 22nd, 2019, episodes. The next segment, from December 17th, features Dr. Peter Doherty.
Dr. Ted Burns, creator and former editor of the Neurology Podcast, discusses the history, process, and meaning of the podcast.
This week, we feature past interviews with Dr. Mike Wilson on metagenomics.
Dr. Stacey Clardy talks with Nobel Laureate Peter Doherty about his collaborative work with Rolf Zinkernagel regarding how the body's immune system distinguishes virus-infected cells from normal cells, among many other topics.
In the first segment, Dr. Jason Crowell talks with Dr. Casey Halpern about his paper on a three-year follow-up of a prospective trial of focused ultrasound thalamotomy for essential tremor. In the second part of the podcast, Will Rondeau talks with Dr. Jared Chen and Dr. Andrew Southerland about statins for neuroprotection in spontaneous intracerebral hemorrhage.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Ted Burns talks with Dr. Stacey Clardy about neuromyelitis optica. In the second part of the podcast, Dr. Jason Crowell talks with Dr. Alberto Ascherio about his paper on physical activity and prodromal features of Parkinson disease.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
This month’s Delayed Recall highlights episodes on the life of Oliver Sacks. Dr. Ted Burns and Oliver Sacks start the show discussing Sacks’ life and experiences as a patient, which first aired in 2010. The next segments, from October 28th and November 4th, 2019, feature Lawrence Weschler, Dr. Sacks’ biographer, discussing the life of the neurologist.
Dr. Stacey Clardy talks with Dr. Sylvia Tenembaum about her paper on prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination.
In the first segment, Dr. Jason Crowell talks with Dr. Joel Salinas about his editorial on neurologists’ duty to treat social ills. In the second part of the podcast, Dr. Teshamae Monteith talks with Dr. Andrew Hershey about his practice guideline update summary paper in Neurology® on pharmacologic treatment for pediatric migraine prevention.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Stacey Clardy continues her talk with Dr. Lawrence Weschler about his book on Oliver Sacks, And How are You, Dr. Sacks?, in the second of a two-part interview. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Andrew Mammen about his paper on more prominent muscle involvement in dermatomyositis patients with anti-Mi2 autoantibodies.
This month's Delayed Recall highlights episodes on CRISPR gene editing technologies. From February 2017, we have an introduction to CRISPR. Then, there's a 2-part interview with Dr. Kevin Esvelt from February 20 and 27, 2018, on gene drives.
In the first segment, Dr. Stacey Clardy talks with Dr. Richard Burt about his paper on autologous, nonmyeloablative hematopoietic stem-cell transplantation for neuromyelitis optica. In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Lawrence Weschler about his book on Oliver Sacks, And How are You, Dr. Sacks?, in the first of a two-part interview.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Jeff Burns talks with Dr. Randall Bateman about his paper addressing how high precision plasma amyloid-β 42/40 predicts current and future brain amyloidosis. In the second part of the podcast, you'll hear the second part of an interview with Nobel Prize winner Dr. Stanley H. Prusiner.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Ylva Hiorth and about their paper on a 7-year prospective population-based study on orthostatic hypotension in Parkinson disease. In the second part of the podcast, Dr. Jason Crowell talks with Nobel Prize winner Dr. Stanley B. Prusiner in the first part of a two-part interview.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Greg Day talks with Dr. Kiran Thakur and Dr. Greer Waldrop about their paper on diagnostics for neurologic disorders on the World Health Organization’s essential diagnostic list. In the second part of the podcast, Dr. Stacey Clardy speaks with Dr. Sean Pittock on his NEJM paper on eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
This month’s Delayed Recall highlights episodes on drug pricing controversies. Dr. Jason Crowell and Professor Robin Feldman start the show discussing “evergreening” and drug prices, which first aired on August 20th, 2019. The next segments, from September 17th and 24th, has Dr. Gordon Smith and Dr. Steve Pearson discussing updates to drug pricing in a follow-up to their earlier talk on the subject. Following this segment is one from May 27th and finds Dr. Jason Crowell talking with Dr. Brian Callaghan about rising out-of-pocket costs for commonly prescribed neurologic medications. This episode concludes with an interview on with Dr. Jason Crowell and Politico reporters Sarah Karlin-Smith and Sarah Owermohle.
In the first segment, Dr. Jason Crowell talks with Dr. Emma Ciafaloni about her clinical/scientific note on combination therapy with nusinersen and AVXS-101 in SMA type 1. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Douglas Smith on neuroimaging findings in US government personnel with possible exposure to directional phenomena in Havana, Cuba.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Stacey Clardy talks with Dr. Mauricio Farez about his practice guideline update summary on vaccine-preventable infections and immunization in multiple sclerosis. In the second part of the podcast, Dr. Gordon Smith continues his discussion with Dr. Steve Pearson on an update on drug pricing. Their previous discussion on drug pricing was featured in two parts on January 8th and January 15th, 2019.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Stacey Clardy talks with Dr. Julie Silver about her paper on understanding and addressing gender equity for women in neurology. In the second part of the podcast, Dr. Gordon Smith focuses his discussion with Dr. Steve Pearson on an update on drug pricing. Their previous discussion on drug pricing was featured in two parts on January 8th and January 15th, 2019.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Noah Kolb talks with Dr. Amanda Guidon about her paper on varied phenotypes and management of immune checkpoint inhibitor associated neuropathies. In the second part of the podcast, Dr. Stacey Clardy focuses her discussion with Dr. Mike R. Wilson on clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. Read the full NEJM article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1803396.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
This month's Delayed Recall highlights interviews with some of the plenary session speakers from this year's AAN Annual Meeting. We highlight talks with Dr. Jonathan Mink, Dr. Claudia Lucchinetti, Dr. Jed Hartings, Dr. Ronald Melki, and Dr. J. Paul Taylor.
In the first segment, Dr. Alex Menze talks with Dr. Jonathan Newmark about his Neurology: Clinical Practice paper that provides an update on therapy for acute nerve agent poisoning. In the second part of the podcast, Dr. Andrew Schomer focuses his discussion with Dr. Jan Claassen on detection of brain activation in unresponsive patients with acute brain injury. Read the full NEJM article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1812757.
Information on managing nerve agent attack can be found here: https://ccc.apgea.army.mil/.
Disclosures can be found at Neurology.org.
No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.
Dr. Stacey Clardy focuses her discussion with Dr. Amanda Grennell on an update on Zika for 2019. Read the full article here: https://www.nature.com/articles/d41586-019-01906-z.
In the first segment, Dr. Stacey Clardy talks with Dr. Anastasia Zekeridou about her paper on Phosphodiesterase 10A-IgG, a novel biomarker of paraneoplastic neurological autoimmunity. In the second part of the podcast, Dr. Jason Crowell focuses his discussion with Prof. Robin Feldman on “evergreening” and drug prices. Read the full article here: https://www.nature.com/articles/d41586-019-01906-z.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Jason Crowell talks with Dr. Michele Hu and Dr. David Okai about their longitudinal study of the severity of impulse control disorders in Parkinson disease and RBD. In the second part of the podcast, Dr. Jason Crowell focuses his discussion with Dr. Heidi Ledford on her Nature article discussing CRISPR babies and what would be required to make gene editing safe and acceptable. Read the full article here: https://www.nature.com/articles/d41586-019-01906-z.
Disclosures can be found at Neurology.org.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Stacey Clardy talks with Dr. Robert Zivadinov about cumulative gadodiamide administration leading to brain gadolinium deposition in early MS. In the second part of the podcast, Dr. Jeffrey Ratliff focuses his discussion with Dr. Michael D. Fox on his Brain paper on network localization of cervical dystonia based on causal brain lesions. You can read the paper here: https://academic.oup.com/brain/article-abstract/142/6/1660/5491101?redirectedFrom=fulltext.
This month's Delayed Recall highlights more interviews from our new podcast offering, Neurology Minute. In 2019, Neurology launched a new podcast perfect for Alexa and other similar devices. This episode features digestible "minutes" from June and July. See the instructions for enabling the Neurology Minute on Amazon Alexa below:
In the first segment, Dr. Kristen Heinan talks with Dr. Barbara Weissman about her Neurology: Clinical Practice paper on recommendations for neurologists on the CDC’s Guideline on Pediatric Mild Traumatic Brain Injury. In the second part of the podcast, Dr. Will Rondeau focuses his discussion with Dr. Geoffrey Donnan on his NEJM paper on thrombolysis guided by perfusion Imaging up to 9 hours after onset of stroke. You can read the paper here: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1813046.
In the first segment, Dr. Gregory Day talks with Dr. Philip Insel about his paper on determining clinically meaningful decline in preclinical Alzheimer disease. In the second part of the podcast, Dr. Sarah Tabrizi talks about targeting Huntington expression in patients with Huntington's disease in her interview with Dr. Jeffrey Ratliff. Read Dr. Tabrizi's paper in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa1900907?query=recirc_curatedRelated_article.
In the first segment, Dr. Halley Alexander talks with Dr. Orrin Devinsky about his paper on the full spectrum of epilepsies and the North American SUDEP Registry. In the second part of the podcast, Dr. Ted Burns focuses his discussion with Dr. Gil Wolfe on his Lancet Neurology paper on the long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis. You can read the paper here: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30392-2/fulltext.
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Franziska Hopfner about her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease. In the second part of the podcast, Dr. Jason Crowell focuses his discussion with Dr. Jerzy Szaflarski on his JAMA Neurology paper on the US Food and Drug Administration’s authorization of the first cannabis-derived pharmaceutical. You can read the paper here: https://jamanetwork.com/journals/jamaneurology/article-abstract/2714720.
In the first segment, Dr. Michelle Mauermann talks with Dr. Bart Jacobs about his paper on current treatment practice of Guillain-Barré syndrome. In the second part of the podcast, Dr. Matthew Harms focuses his discussion with Dr. Guy Rouleau on his Neurology: Genetics paper looking at how somatic expansion of the C9orf72 Hexanucleotide Repeat does not occur in ALS spinal cord tissues.
This month's Delayed Recall highlights interviews on epilepsy and EEG. Dr. Derek Bauer talks with Dr. Paula Emanuela Voinescu about her paper on antiepileptic drug clearances during pregnancy and the relationship between drug serum concentration and seizure frequency from the Sept 25, 2018, podcast. Next, Dr. Andy Schomer talks with Dr. Chloe Hill on the association between continuous EEG and favorable hospitalization outcomes for critically ill patients from the January 1, 2019, podcast. For the next segment, we’re back with Derek Bauer, this time talking with Dr. Jacqueline French about the recent practice guideline on the treatment of new-onset epilepsy from the July 10, 2018 episode. And then again from the April 2, 2019, podcast, we hear Derek Bauer talk with Dr. Stephan Schuele about his paper on automated seizure detection accuracy for ambulatory EEG recordings. Finally, we wrap up with Jeff Ratliff talking to Dr. Anup Patel about the 2017 epilepsy quality measurement set update, which originally aired on the October 30, 2018, podcast.
In the second part of a 2-part interview, Dr. Bob Gross discusses changes to the journal and publishing as well as some controversies and challenges as Editor-in-Chief of Neurology.
In the first part of a 2-part interview, Dr. Bob Gross discusses his experiences, opportunities, and challenges as Editor-in-Chief of Neurology.
Dr. Stacey Clardy talks with Dr. P. James B. Dyck about his paper on the incidence of lumbrosacral radiculoplexus neuropathy and association with diabetes mellitus.
Dr. Jason Crowell focuses his talk with Dr. Deborah Dowell on her NEJM perspective article looking at opioid prescribing and response to the CDC guidelines. You can read Dr. Dowell’s paper here: https://www.nejm.org/doi/full/10.1056/NEJMp1904190.
This month's Delayed Recall highlights interviews from our new podcast offering, Neurology Minute. In 2019, Neurology launched a new podcast perfect for Alexa and other similar devices. This episode features digestible "minutes" on measles in 2019, gene editing, the SHINE stroke trial, and more.
In the first segment, Dr. Jason Crowell talks with Dr. Brian Callaghan about rising out-of-pocket costs for commonly prescribed neurologic medications. In the second part of the podcast, Dr. Jeffrey Ratliff focuses his interview with Dr. Stefan Pulst on ataxias.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
In the first segment, Dr. Stacey Clardy talks with Dr. Annie Lannuzel about the importance of biological diagnosis in long-term outcome in neuroZika. In the second part of the podcast, Dr. Will Rondeau focuses his interview with Dr. Stuart Connolly on his NEJM paper on the full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. The paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa1814051.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
This month’s Delayed Recall highlights episodes on developments and scandals related to genetic testing and technology in neurology. Dr. Jason Crowell and Dr. Josephine Johnston of the Hastings Center start the show discussing the ethical and philosophical implications of gene editing., which first aired on December 18th, 2018. The next segment, also from December 18th, has Dr. Stacey Clardy and Dr. Stefan Pulst focusing on the scientific and societal impact of the recent first reported gene editing using the CRISPR technology. Following this segment is one from December 3rd and finds Dr. Jeff Waugh talking with Dr. Saadet Andrews about her paper on the genetic landscape of pediatric movement disorders and management implications. This episode continues with an interview on a Neurology: Genetics on the long journey to diagnosis for patients with mitochondrial disease between Dr. Jason Crowell and Drs. John L.P. Thompson and Michio Hirano from April 3rd, 2018. The episode wraps up with a talk between Dr. Jeffrey Ratliff and Dr. Thomas Bird from March 20th, 2018, on Dr. Bird’s Neurology: Clinical Practice paper on the benefits and limitations of exome sequencing to identify hereditary ataxias.
In the first segment, Dr. Lindsay Higdon talks with Dr. Ivan Sanchez Fernandez about his paper on the meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Fauci about the measles outbreak of 2019. You can read the paper in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMp1905099.
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Tamara Milka Pringsheim about her practice guideline recommendations summary paper on the treatment of tics in people with Tourette syndrome and chronic tic disorders. In the What's Trending segment, you'll hear the second part of an interview between Dr. Jason Crowell and New York Times staff writer Pam Belluck on CRISPR and gene editing.
In the first segment, Dr. Stacey Clardy talks with Dr. Jenny Linnoila about her March 2019 Neurology: Neuroimmunology & Neuroinflammation paper on a mouse model of anti-NMDA receptor post–herpes simplex encephalitis. In the second segment, Jason Crowell talks with Pam Belluck of the New York Times about He Jiankui, gene editing, and CRISPR.
In the first segment, Dr. Gregory Day talks with Dr. Brigid Waldron-Perrine about her Neurology: Clinical Practice paper addressing the Montreal Cognitive Assessment as a screening tool. In the second part of the podcast, Dr. Jeffrey Burns focuses his interview with Dr. Mathias Jucker on how serum neurofilament dynamics predict neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. The article can be found in Nature: https://www.nature.com/articles/s41591-018-0304-3.
In the first segment, Dr. Stacey Clardy talks with Dr. Mathias Buron about his paper addressing the comparative effectiveness of teriflunomide and dimethyl fumarate. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Dr. Joanna Hellmuth on the rise of pseudomedicine for dementia and brain health.
In the first segment, Dr. Stacey Clardy talks with Dr. Caterina Lapucci about her paper addressing how much periventricular lesions assist in distinguishing migraine with aura from CIS. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Sarah Karlin-Smith and Sarah Owermohle from Politico on drug pricing.
In the first segment, Dr. Derek Bauer talks with Dr. Stephan Schuele about his paper on automated seizure detection accuracy for ambulatory EEG recordings. In the second part of the podcast, Dr. Nicole Chiota-McCollum focuses her interview with Dr. Kevin Barrett on the SHINE stroke trial.
Dr. Luca Bartolini discusses autoimmune encephalitis and the role of antibody testing based on a Practice Current survey run between November 2017 and May 2018.
Dr. Jeffrey Ratliff talks with Dr. Anneleen Berende about her paper on the effect of prolonged antibiotic treatment on cognitive performance in patients with Lyme borreliosis. Dr. Andrew Southerland focuses his interview with Dr. Stephen Klasko on hospitals of the future, following a panel at the World Economic Forum in Davos, Switzerland. The article can be found here: https://www.statnews.com/2019/01/26/dispatch-from-davos-future-hospitals/.
This month’s Delayed Recall highlights episodes on autoimmune neurology. A segment from October 23, 2018 finds Dr. Stacey Clardy talking to Dr. Andrew McKeon about his paper on paraneoplastic neuronal intermediate filament autoimmunity. This episode concludes with an interview on a Neurology: Neuroimmunology & Neuroinflammation paper on IgLON5 autoimmunity between Dr. Stacey Clardy and Dr. Andrew McKeon from March 27, 2018.
In the first segment, Dr. James Grogan talks with Dr. David Llewellyn about his Neurology: Clinical Practice paper on predictors of dementia misclassification when using brief cognitive assessments. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Dr. Rob M.A. de Bie on a randomized delayed-start trial of Levodopa in Parkinson’s Disease, published in the New England Journal of Medicine. The article can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa1809983.
1. A multicentre comparison of MOG-IgG cell based assays. 2. [What’s Trending]: the DEFUSE 3 study.
In the first segment, Dr. Stacey Clardy talks with Dr. Paddy Waters about his paper on a multicentre comparison of MOG-IgG cell based assays. In the second part of the podcast, Dr. Andrew Southerland focuses his interview with Dr. Adam de Havenon on the DEFUSE 3 study.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
1. The prevalence of MS in the United States: A population-based estimate using health claims data.
2. [What’s Trending]: Neurology on the Hill and advocacy issue. In the first segment, Dr. Stacey Clardy talks with Dr. Mitch Wallin about his paper examining a population-based estimate on the prevalence of MS in the United States. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Dr. Nick Johnson on Neurology on the Hill and advocacy issues.
CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
1. Quality Improvement in Neurology: Universal Neurology Quality Measurement Set Executive Summary2. [What’s Trending]: The 2018 report of the Lancet Countdown on health and climate change: shaping the health of nations for centuries to come. In the first segment, Dr. Stacey Clardy talks with Dr. Wayne Anderson and Dr. Justin Martello about their paper on quality improvement in neurology. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Dr. Nick Watts on health and climate change shaping the health of nations for centuries to come. DISCLOSURES: Dr. Stacey Clardy has received research support from Western Institute for Biomedical Research (WIBR). Dr. Wayne Anderson reports no disclosures. Dr. Justin Martello has received travel funding or speaker honoraria from 1) Teva, cash, (2) Abbvie, cash, (3) Lundbeck, cash and is a member of the AAN’s Quality and Safety Subcommittee. CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.
1.Physical activity, common brain pathologies, and cognition in community-dwelling older adults 2. [What’s Trending]: Deep space medicine. In the first segment, Dr. Jeff Burns talks with Dr. Aron Buchman about his paper on physical activity, common brain pathologies, and cognition in community-dwelling older adults. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Dr. Alejandro Rabinstein on the medicine of deep space. Dr. Jeff Burns has served on the DSMB for three NIH-funded trials; has received honorarium and travel for speaking at an Astra-Zeneca symposium; has served on the editorial board of Journal of Alzheimer's Disease; has served as a consultant for protocol development for Stage 2 Innovations; has received commercial research support from Lilly, Avid Radiopharmaceuticals, Toyama Chemical Company, Merck, Biogen, AbbVie, vTv Therapeutics, Janssen, and Roche and for investigator-initiated studies from Eli Lilly and Astra-Zeneca; has received governmental research support from the National Institutes of Health; and has provided expert witness testimony in legal cases. Dr. Aron Buchman has received government research support from the National Institutes of Health. Dr. Jason Crowell reports no disclosures. Dr. Alejandro Rabinstein has served as a member of the external committee for adverse event adjudication for PREVAIL trial/CAP2 registry; has served on the editorial boards of Neurology, Neurocritical Care, Stroke, CONTINUUM , and UpToDate; and has received publishing royalties from Elsevier and Oxford.
Dr. Alex Menze focuses his interview with Claudia Angeli on recovery of over-ground walking after chronic motor complete spinal cord injury.
Dr. Derek Bauer talks with Dr. Jacqueline French about her paper, a summary of a recent practice guideline on the treatment of new-onset epilepsy.
Dr. Brian Eckerle talks with Dr. Rob van de Graaf about his paper on conscious sedation vs local anesthesia during endovascular treatment for ischemic stroke.
Dr. Stacey Clardy talks with Dr. Shelly Benjaminy about her paper on patients’ perspectives from the chronic cerebrospinal venous insufficiency clinical trial in Canada.
Dr. Alex Menze interviews Dr. Kelly Gwathmey about her paper on a new quality of life measure for diabetic polyneuropathy.
Dr. Roy Strowd talks with Dr. Saman Zafar about her paper on amateur fundus photography.
Dr. Ted Burns interviews Dr. Clinton Wright about his paper on leisure time physical activity and how it is associated with cognitive decline. Dr. Alberto Espay interviews Dr. Jeremy Schmahmann about his Frontiers in Neuroscience Plenary Session at the AAN meeting about the implications for neurology and psychiatry in the treatment of cerebellar cognitive affective syndrome.
Stroke in Systemic Disease. Lesson of the Week interviews from March 2015.
Podcasten Neurology® Podcast är skapad av American Academy of Neurology. Podcastens innehåll och bilderna på den här sidan hämtas med hjälp av det offentliga podcastflödet (RSS).
En liten tjänst av I'm With Friends. Finns även på engelska.